The future of hospitals and pharmaceutical companies will indeed rely heavily on the strength of healthcare analytics insights. Here’s why: 1. Improved Patient Outcomes: Advanced analytics can help predict patient needs, improve diagnostic accuracy, and personalize treatments. Hospitals can use this data to prevent complications, reduce readmission rates, and enhance patient satisfaction. 2. Operational Efficiency: Analytics can streamline hospital operations, optimizing resource allocation, staff scheduling, and supply chain management. This leads to reduced costs and better service delivery. 3.Predictive Analytics: Hospitals and pharma companies can utilize predictive models to foresee trends such as disease outbreaks, drug demand, or patient admissions, allowing them to prepare and respond more effectively. 4. Drug Development: In pharma, big data and AI-driven analytics accelerate drug discovery, clinical trials, and regulatory processes. Insights from patient data, genetics, and real-world evidence lead to more effective and targeted therapies. 5. Population Health Management: Analytics enables tracking and managing population health, identifying at-risk groups, and implementing preventive care strategies. Hospitals can collaborate with pharma companies to create personalized medicines or interventions based on these insights. 6. Value-Based Care: Healthcare is moving towards value-based care models, where reimbursement is based on patient outcomes rather than the volume of services provided. Analytics will help track performance, measure outcomes, and ensure compliance with these models. 7. Regulatory Compliance and Risk Management: Insights from analytics help in maintaining compliance with regulations like HIPAA or GDPR, as well as managing risks, from cybersecurity threats to adverse drug reactions. The integration of healthcare analytics into the core operations of hospitals and pharmaceutical companies is a critical step toward a more data-driven, efficient, and personalized future for healthcare. SOURCE- Medcitynews #HealthcareAnalytics #FutureOfHealthcare #DataDrivenHealthcare #PharmaInnovation #PatientOutcomes #PredictiveAnalytics #DigitalHealth #HealthTech #ValueBasedCare #BigDataInHealthcare

Family Offices in India Betting Big on Generative AI In recent years, India’s family offices have quietly joined the race to invest in generative AI (GenAI) startups, both domestically and internationally. While venture capitalists and private equity firms have dominated the spotlight, family offices have emerged as key players, recognizing the potential of AI to shape future industries. Between 2021 and September 2024, Indian family offices invested nearly $570 million in AI-focused companies, with a significant $259 million allocated in 2024 alone, signaling their growing interest in this transformative technology. Premji Invest: Leading the Charge Among the frontrunners is Premji Invest, the family office founded by philanthropist and businessman Azim Premji. The firm made three out of the four largest AI investments in 2024, with notable stakes in Colorado-based Enveda and talks to back San Francisco-based AI startup Galileo. Premji Invest has strategically diversified its portfolio by supporting global AI companies, including Hugging Face, Hippocratic AI, and Cohesity. Its investments extend beyond borders, with Indian startups like Questt and Binocs also receiving support. Manjot Pahwa, head of early-stage technology investments at Premji Invest, stated, “We’re evergreen capital and excited to back companies with the potential to build businesses that last generations, across India and the US, from Series A to pre-IPO.” AI: A Global Growth Story with Indian Opportunities Globally, generative AI investments have reached $59.2 billion, with 63% of that figure raised in 2023 alone. The generative AI space is booming, and according to Neha Singh, co-founder and CEO of Traxcn, 2024 has already seen $18 billion in global funding, marking a 10.4% increase from the previous year. While India remains a nascent market for AI, the outlook is optimistic, and family offices are anticipated to play a larger role in this growth story. Family offices like Reddy Ventures, led by GV Sanjay Reddy, are also taking a significant interest in AI. Reddy Ventures has backed tech disruptors like Cred, Hive, and KhataBook, and Reddy recently cofounded Jivi, an AI-driven healthcare platform. "The pace of change is going to be faster than we can imagine," says Reddy, who has committed to investing in five AI-driven companies over the next five years. Strategic and Cautious Investments Indian family offices are showing a particular interest in seed-stage AI startups. For instance, RAAY Investments, the family office of investor Amit Patni, recently invested $1.5 million in Neural Garage, a deeptech SaaS startup. The firm is focused on innovative technologies that offer disruptive potential. “We are constantly on the lookout for some breakthrough ideas which can shape the future of how people consume things,” said RAAY's Chief Investment Officer, Benaifer Malandkar. Unlike their U.S. counterparts, Indian investors are more inclined toward AI applications rather than hardware or model training. As Prateek Agarwal, CEO of Motilal Oswal Asset Management, explains, “India is more inclined towards the application side of AI.” Family offices either invest independently or co-invest with private equity firms, leveraging the expertise of seasoned investors to balance their risk profiles. The Future of GenAI Investments in India As the generative AI landscape continues to evolve, Indian family offices are positioned to play a pivotal role. Their strategic investments in AI startups—whether in healthcare, SaaS platforms, or other sectors—underscore the growing belief that AI is more than a trend; it’s a transformative force that will reshape industries worldwide. As more family offices join the fray, the next wave of AI innovations may very well have an Indian footprint. With an eye on both local and global opportunities, family offices in India are taking calculated risks, eager to back the AI revolution and create lasting impact across sectors and geographies. Source: The Economic Times #healthcarestartup #startupfunding #dseide #startup

Wolters Kluwer is gearing up to showcase its cutting-edge AI and care delivery innovations at HLTH 2024, taking place from October 20-23 in Las Vegas . From applying AI in care delivery and personalizing care engagement in traditional and nontraditional care settings like retail pharmacies, to leveraging enterprise analytics, these demonstrations will highlight the company’s approach to unlocking value across the care continuum. This premier healthcare conference is the perfect platform for Wolters Kluwer to demonstrate how its solutions can drive effective clinical decision-making and improve health outcomes. Some of the key highlights of Wolters Kluwer's showcase include: 1.Generative AI in Care Delivery: Experts from Wolters Kluwer will discuss the potential of generative AI to transform care delivery, addressing concerns around reliability and underlying content . 2. AI-Enhanced Clinical Decision Support: The company will demonstrate its UpToDate suite, featuring AI-driven clinical decision-making tools and analytics . 3.Collaborations for Responsible AI Use: Wolters Kluwer will highlight its partnerships with organizations like the Coalition for Health AI (CHAI) to promote safe and effective AI deployment in healthcare . SOURCE-Businesswire #HLTH2024 #WoltersKluwer #HealthcareInnovation #AIinHealthcare #ClinicalDecisionSupport #HealthTech #DigitalHealth #HealthcareTechnology #MedicalInnovation #ArtificialIntelligence

Collaboration Across Borders and Sectors: Essential for Lasting Health Solutions On October 14, 2024, Union Health Minister J. P. Nadda emphasized the importance of collaboration across borders, sectors, and disciplines in creating lasting health solutions. Speaking at the inauguration of the 19th International Conference of Drug Regulatory Authorities, organized by the Central Drugs Standard Control Organisation (CDSCO), he reinforced India's commitment to meeting the growing demand for pharmaceutical products while adhering to global quality standards. The conference brought together experts and leaders from over 120 countries, demonstrating India's shared dedication to enhancing healthcare and safeguarding public health. India’s Pharma Commitment to Global Standards As the world’s demand for high-quality medicines continues to increase, India is stepping up its efforts to ensure that its pharmaceutical products meet the highest global standards. Mr. Nadda highlighted that India’s national regulatory body, the CDSCO, plays a pivotal role in approving safe and effective drugs and medical devices, both for domestic use and export to more than 200 countries. He underscored that the availability of affordable, high-quality medicines lies at the heart of India’s healthcare mission. Strengthening Regulatory Frameworks and Drug Testing India's regulatory landscape has seen significant advancements. The country has established eight operational drug testing laboratories, with two more in the pipeline. Additionally, eight mini testing labs have been set up at ports, enabling quick testing and release of imported drugs and raw materials. This infrastructure is crucial in ensuring that the pharmaceutical supply chain remains robust and transparent. To further strengthen the drug supply chain, Mr. Nadda announced the introduction of barcodes or QR codes on the top 300 brands of pharmaceutical products, ensuring that every package can be tracked and verified. This initiative extends to active pharmaceutical ingredients (APIs), which must also carry QR codes, whether imported or manufactured in India. This step enhances the traceability of drug products and raw materials, building trust among consumers and stakeholders. Digitalization and Transparency One of the most notable achievements mentioned by the Union Minister was the digitization of over 95% of CDSCO's regulatory processes. This digital shift has not only improved efficiency but has also brought transparency, which is critical in fostering trust between regulators, manufacturers, and consumers. The digitalization of regulatory frameworks ensures that companies can access information, file approvals, and monitor compliance more easily, thus streamlining the drug approval process. This is especially important in a globalized world where the seamless exchange of pharmaceutical products is vital for public health. Regulating Medical Devices In recognition of the growing importance of medical devices in healthcare, India has strengthened its regulatory framework for this sector as well. The country has amended its drug rules to align more closely with international standards, including the WHO's Good Manufacturing Practice (GMP) guidelines. This ensures that medical devices produced in India adhere to the same rigorous standards as pharmaceutical products, further cementing India’s position as a global leader in healthcare solutions. Conclusion: A Global Commitment to Health Minister Nadda’s speech highlights India’s steadfast commitment to improving global healthcare by fostering collaboration and adhering to stringent quality standards. As the pharmaceutical and medical device industries continue to evolve, India is taking proactive steps to ensure that the products it develops meet the demands of the world while safeguarding public health. Through ongoing collaboration with international regulatory authorities, India is poised to play an increasingly vital role in shaping the future of healthcare globally. Source: The Hindu #healthcarestartup #healthcaredevices #startup #dseide

Early-stage startups are up against stronger filters for their next round of funding than before as the downturn in risk capital investing has investors taking a harder look at some of the ventures they funded. A new study by data analytics platform Venture Intelligence showed only one in four startups that secure seed funding manage to raise follow-on capital in the form of a Series A round. In the last 12-15 months, several startups have been shuttered for the lack of product market fit. These include Tiger Global and Peak XV Partners-backed software firm Toplyne, Elevation Capital and Lightspeed-backed edtech venture Bluelearn, Peak XV-backed artificial intelligence startup Nintee, and GSV Ventures-backed upskilling startup FrontRow. While Toplyne raised a total of $17.5 million, Bluelearn and Nintee had raised $3.95 million and $3 million respectively in funding from venture capital investors before shutting down. In line with the broader funding slowdown in India’s startup ecosystem, the number of companies that attracted series A funding in 2023 dropped by 45% to 127, down from 232 startups in 2022, the Venture Intelligence report showed. This is 23% below the average of 166 deals recorded over the past eight years .. Early stage investing is all about risk taking…obviously the power law comes into play and so you will see a lot of startups shutting down after raising seed funding but that doesn’t create a negative force on the larger ecosystem. It is a healthy trend that those without a PMF (product market fit) take a call to move on without burning a single dollar more than is justified,” a partner of a Bengaluru-based early-stage firm said. He added that this trend could rise as more investors take “bolder bets on the new AI wave.” According to a report by 1Lattice, for the quarter-ended September 30, software-as-a-service and artificial intelligence (AI) were the most attractive sectors for early-stage investing garnering a total of $142 million. This includes a $27.5 million round for Mukesh Bansal’s AI startup Nurix. Karthik Reddy, founder and managing partner of early-stage venture capital firm Blume Ventures that backed startups such as Unacademy, Purplle, Spinny and Exotel, said that the funding funnel takes a long time to develop and that short-term seasonality should not be confused with long-term averages. “There’s a natural funnel anywhere in the world. You cannot have the same amount of series A players as you have seed players, and therefore there is always a rapid funnelling,” he said. Source: The Economic Times #healthcraestartup #startupdevices #dseide #startupfunding #startrups

The National Health Authority, the implementing agency for the Ayushman Bharat Pradhan Mantri Jan Arogya Yojana (AB-PMJAY), is assessing the need to add more health packages catering to the elderly as the government is set to roll out the health coverage for all aged 70 years and above. The expanded scheme, which will benefit an estimated six crore citizens in about 4.5 crore households, is likely to be launched by the end of this month, official sources said. "The committee which decides on health-benefit packages under the scheme is deliberating on the need for adding more health packages, which exclusively tend to geriatric care, as the number of such beneficiaries will go up with the aunch of the scheme," an official source said. The scheme presently offers a comprehensive coverage that includes 1,949 medical procedures across 27 medical specialties, such as general medicine, surgery, oncology and cardiology. Hospital services, including drugs (covering 15 days' medication post-discharge), diagnostics (up to three days before admission), food and lodging, are provided at no cost to the beneficiaries. "The admissions necessitated due to certain mental-health conditions, such as Alzheimer's and dementia, are also covered under the current scheme," the source said. #ElderlyCare #HealthcareForAll #ABPMJAY #AyushmanBharat #SeniorCitizenCare #GeriatricHealth #UniversalHealthcare #HealthyAging #IndiaHealthcare SOURCE-THE ECONOMIC TIMES

Ratan Tata, the Chairman Emeritus of Tata Sons, is widely revered for his business acumen and philanthropic endeavors. However, a lesser-known chapter of his illustrious career is his remarkable involvement in nurturing India's startup ecosystem. Over the years, Tata emerged as a visionary investor, backing a number of startups that would go on to become major players in their respective industries. What stood out about his approach was his belief that investing in startups was not just a financial venture but a continuous “learning experience” that kept him connected to new trends and innovations, regardless of age or experience. One of his most notable investments was in Paytm, a company that started as a mobile recharge platform. Tata’s early backing helped Paytm lead a digital revolution in India, transforming it into one of the country’s foremost fintech giants, offering services that range from digital wallets to banking and financial solutions. Tata also supported Ola, a local competitor to global ride-hailing giant Uber. Ola started as a ride-hailing service and has since evolved into a diversified company with three major divisions: Ola Cabs, its core ride-hailing business; Ola Electric, its electric vehicle arm; and ‘Krutrim,’ its AI offshoot. His faith in Ola demonstrated his foresight in backing businesses that weren’t just disruptors but were also focused on sustainability and future technologies. Apart from these, Tata invested in Snapdeal, a major e-commerce platform, and many other startups that reflect his ability to recognize potential long before these companies became household names. His approach was always grounded in a deep understanding of human capital, talent, and the evolving demands of consumers, underscoring his belief in the importance of adaptability in the modern business landscape. Ratan Tata’s investment philosophy wasn’t just about profit; it was about empowering the next generation of entrepreneurs. His willingness to bet on young talent and innovative ideas has left an indelible mark on the startup ecosystem, both in India and globally. His legacy as an investor is a blend of sharp business insight, a passion for learning, and a desire to contribute to the greater good of society. Source: Beyond Business #healthcarestartup #startups #dseide

DHN Healthtech Innovation Challenge 2024: MedySeva Takes the Top Spot; Karnataka Health Minister Dinesh Gundu Rao Applauds Healthcare Innovation Bengaluru – The DHN Healthtech Innovation Challenge 2024 concluded on a high note, with MedySeva emerging as the top innovator among a pool of groundbreaking healthcare startups. The event, aimed at fostering cutting-edge solutions in the healthcare sector, attracted participation from over 50 startups nationwide, showcasing technologies that promise to reshape the future of healthcare delivery. The prestigious challenge, held as part of the larger DHN Health Summit, culminated with Karnataka's Health Minister Dinesh Gundu Rao presenting the award to MedySeva for their novel telemedicine platform designed to extend healthcare access to rural and underserved communities. The platform uses AI and remote monitoring to bridge the gap between patients and doctors, offering real-time consultations and diagnostic services. Minister Rao commended the participants for their contributions to healthcare innovation, stating, "MedySeva and the other finalists demonstrate that India's healthtech sector is at the forefront of global innovation. These solutions will play a crucial role in making healthcare more accessible, efficient, and patient-centered." With innovations ranging from AI-powered diagnostic tools to digital therapeutics, the challenge highlighted the critical role of technology in transforming healthcare, especially in regions with limited access to medical infrastructure. SOURCE-Business Standard #DHNHealthtech2024 #MedySeva #HealthcareInnovation #HealthtechChallenge #KarnatakaHealthcare #DigitalHealth #Telemedicine #AIinHealthcare #InnovationForGood #FutureOfHealthcare

Reliance Ventures into Quick Commerce: What You Need to Know Reliance Industries has entered the quick commerce space, offering its services in select regions of Navi Mumbai and Bengaluru through JioMart, its ecommerce platform. This new offering is focused on delivering groceries from its 3,000 retail stores nationwide. Reliance plans to expand its product range soon, adding value fashion and small electronics like smartphones, laptops, and speakers, according to a senior company executive. Scaling Up for Speed Reliance's quick commerce venture is set to scale up across India by the end of this month. The aim is to fulfil most orders in 10-15 minutes, while some may take up to 30 minutes. To achieve this, the company will rely on its existing retail network, including stores like Reliance Digital and Trends. Additionally, Reliance will use Grab, a logistics service it previously acquired, to manage delivery fulfilment. Unlike other quick commerce operators, Reliance does not plan to open dark stores or neighbourhood warehouses. Instead, the company will use its extensive physical store network for order fulfilment, streamlining its operations without the need for dedicated infrastructure. The Quick Commerce Surge Quick commerce, which typically promises ultra-fast delivery within 10 to 30 minutes, is rapidly becoming the fastest-growing segment in the ecommerce market. FMCG (fast-moving consumer goods) companies are seeing this channel account for 30-35% of total online sales. With demand for instant gratification and convenience soaring, quick commerce has become the key battleground for major ecommerce players. Reliance’s quick commerce initiative isn’t their first attempt. The company previously launched a separate app for quick deliveries under the ‘Express’ service, which was eventually discontinued in February last year. This new venture marks Reliance’s second attempt, this time leveraging its vast retail footprint and logistics network. A Competitive Landscape The Indian quick commerce market is bustling with competition. Companies like Zepto, Amazon, Flipkart, and BigBasket are vying for market share, each deploying unique strategies to optimize delivery times and secure a loyal customer base. Cash-rich quick commerce firms are racing to acquire dark store sites and scale operations to meet growing demand. Reliance’s decision to forgo dark stores sets it apart from other players in the market, with the company betting on its physical store network to outperform the competition. The Broader Impact As quick commerce becomes increasingly popular, it’s diversifying fast. Beyond groceries, electronics, and fashion, the model is set to expand into a wider array of consumer categories, reshaping how people shop online. Reliance’s entry into this market could spark significant changes across the ecommerce and retail landscape. Whether it will dominate this space remains to be seen, but with its deep pockets, nationwide reach, and logistics strength, Reliance is well-positioned to be a major player in India's quick commerce revolution. Source: The Economic Times #healthcarestartup #startup #dseide #startupfunding

Indian healthcare companies like MrMed are revolutionizing the concept of affordable and accessible care, redefining the standards for quality and affordability in the industry. Here's how: Key Innovations: 1.Telemedicine: MrMed and similar platforms offer virtual consultations, making healthcare accessible to rural and underserved populations. 2.Affordable Pricing: They provide cost-effective services, reducing financial burdens on patients. 3.Doorstep Services: MrMed offers home delivery of medicines and diagnostic services, ensuring convenience. Impact: 1.Increased Accessibility: Expanding healthcare reach to remote areas. 2.Cost Reduction: Making quality care affordable for low-income households. 3.Improved Health Outcomes: Early diagnosis and treatment due to increased accessibility. Future Directions: 1.Technological Integration: AI-powered diagnostics and personalized medicine. 2.Partnerships and Collaborations: Strengthening ties with healthcare providers and insurers. 3.Expansion and Scalability: Reaching more underserved populations. Challenges and Opportunities: 1.Regulatory Framework: Navigating policy changes and compliance. 2.Quality Control: Maintaining standards in affordable care. SOURCE - eHealth 3.Public Awareness: Educating consumers about affordable options. #MakeHealthcareAccessible #IndiaHealthcare #HealthcareInIndia #IndianHealthcareSystem #HealthcareForAllIndia

Nitish Bajaj, who was the chief executive officer and a senior management personnel at Piramal Consumer Products Division, Piramal Pharma, has stepped down from his position, in order to pursue opportunities outside the organisation. Bajaj's last working say is on November 14, and Sarosh Shetty will be the interim CEO, India Consumer Healthcare, Piramal Pharma Limited. Bajaj began his career at Steel Authority of India and went on to work across HJ Heinz, Ranbaxy Consumer Healthcare, Reckitt Benckiser and CEAT Tyres. Shetty brings 27 years of experience in leading global consumer driven organisations such as Hershey, Unilever, Mahindra & Mahindra, Whirlpool and Colgate Palmolive. This includes marketing and business leadership roles, both in India and globally. He has strong expertise in business strategy development, marketing planning, brand building, multi-channel communication, process transformation, innovation strategy, commercial initiatives, and organizational leadership. In recent years, Shetty has worked as an independent consultant, driving business strategy and growth for various consumer-focused businesses. In his last corporate role, he was in a global leadership role as the Director for Strategic Growth and Innovations for international markets at The Hershey Company. Sarosh holds an M.B.A in Marketing from the Symbiosis Institute of Business Management; and a Bachelor of Engineering (Mechanical) from the University of Pune. Source: StoryBoard18 #healthcarestartup #dseide #healthcaredevices #startup

Introducing Natur Labs: Pioneering Online Health Care Services Hello everyone, I’m excited to introduce you to Natur Labs, a company dedicated to transforming the way we approach health care. We invite you to join them on this journey toward a healthier future. Your support and engagement are invaluable as they work to revolutionize health care delivery and improve lives. Join them at [Naturlabs] Thank you!

While the UK’s Presymptom Health is by no means alone among healthcare startups globally in using artificial intelligence (AI) to offer products or services that would not otherwise be possible, it is undoubtedly unique among those doing so in how it came about. Founded in 2019, the company was spun out of Ploughshare, a Ministry of Defence (MoD)-owned entity created in 2005 to commercialise intellectual property (IP) from UK defence and government research. Ploughshare identified work by the MoD’s Defence Science and Technology Laboratory (Dstl) research and development agency as being potentially transformative for infection diagnosis. Initially focussed on sepsis, the technology could determine whether a patient would develop the condition up to three days before symptoms appeared. Trained on data from a 12-year study, it used AI and its subset machine learning (ML) to diagnose infection at an earlier stage and with higher accuracy than was previously possible. “They were gathering many samples and lots of data from 4,500 patients, some of which would go on to develop illness,” explains Iain Miller, CEO of Presymptom Health, to Medical Device Network. “The insight was, if you recruit them before they’re sick, you create a resource to train an algorithm that sees the sickness coming rather than reacting to it and picking it up when it’s rather late and you might have less opportunities.” The output of that study, which was started shortly after 2000, was a biobank containing in the region of 70,000 samples – a resource that would become all the more valuable as the emergence of AI during the 2010s allowed for a step change in data interrogation. “We had this huge resource, and this is a classic case of where you can use machine learning,” says Miller. “You’ve got a lot of data, and, to use the parlance of AI and machine learning, they talk about having a lot of ‘features’. What you’ve got is a lot of features in your data, and you’ve got outcomes of interest, so you’re trying to train up a set of features that are diagnostic or predictive of the outcome of interest. Source: Medical Device Network #healthcarestartup #startup #healthcaredevice #dseide

The fund will come on board as a cofounder of the Gurgaon-headquartered startup alongside Ankur Jain, former chief product officer at BharatPe, and GV Sanjay Reddy, chairperson of Reddy Ventures. The investment was concluded last week, for an undisclosed amount, Jain and Reddy told ET. They did not share the amount AI Fund has invested and the stake it acquired. People aware of the development said Ng’s fund has acquired a 20-30% stake in the company founded in January this year. “AI is transforming healthcare, and Jivi takes an important step toward more equitable, precise, and personalised care,” said Andrew Ng, managing general partner at AI Fund. “Ankur and team are at the forefront of this transformation and are developing accessible and intelligent tools. AI Fund is excited to advance this vision together with Jivi.” Speaking to ET in August, Ng had said, “We seem to be fortunate to come across a lot of exciting opportunities to build valuable AI projects.” He had further said India has a significant opportunity to build AI solutions to solve problems in particular sectors. “The biggest opportunity for India is to look at the sectors where the Indian economy is already strong and figure out the applications of AI to those sectors that enable it to maintain its advantages,” he had said. Jivi’s AI products include a health assistant for consumers, which will make healthcare more accessible, and a copilot for doctors that will help ease the burden on the healthcare system, said Jain, chief executive of Jivi. Reddy added that the aim is to keep the core of Jivi’s offerings available for free to the public, and that additional features will be developed to eventually help monetise the products. Source: The Economic Times #healthcarestartup #startup #dseide #healthcarefunding

Here are three things AI startups and investors must know to clear hurdles in healthcare technology markets: 1. Regulatory Compliance *Understand HIPAA, GDPR, and other data protection regulations. *Ensure compliance with FDA guidelines for medical devices and software. *Navigate complex regulatory frameworks in different markets. 2. Clinical Validation and Integration *Conduct rigorous clinical trials to validate AI-driven solutions. *Integrate AI solutions with existing electronic health records (EHRs) and healthcare systems. *Collaborate with healthcare professionals to ensure seamless workflow integration. 3. Cybersecurity and Data Privacy *Implement robust data encryption and access controls. *Protect sensitive patient data from cyber threats and breaches. *Ensure transparency in data usage and sharing practices. By understanding these factors, AI startups and investors can better navigate the complex healthcare technology market and overcome hurdles to success. #AIinHealthcare #HealthcareAI #MedicalAI #AIHealthTech #MachineLearningInHealthcare HealthcareRegulation #ComplianceInHealthcare #HIPAA #GDPR #FDAguidelines SOURCE-AI IN HEALTHCARE

MedLern and Peerless Hospital joining forces can indeed bring about a significant impact on healthcare training and patient care. Here are some potential implications of this partnership: 1.Revolutionizing Healthcare Training: Standardized Training: MedLern's expertise in medical education and training can help standardize Peerless Hospital's training programs, ensuring consistency and quality. 2.Simulation-Based Learning: MedLern's simulation-based training solutions can enhance Peerless Hospital's training capabilities, allowing healthcare professionals to practice and hone their skills in a realistic, risk-free environment. 3. Continuing Education: The partnership can provide ongoing education and training opportunities for healthcare professionals, staying updated on the latest medical advancements and best practices. 4. Elevating Patient Care: Improved Clinical Outcomes: Enhanced training for healthcare professionals can lead to better patient outcomes, reduced errors, and improved quality of care. 5. Personalized Care: MedLern's training programs can focus on patient-centered care, empowering healthcare professionals to provide more empathetic and effective care. 6. Innovative Treatment Options: The partnership can facilitate the adoption of innovative treatments and technologies, further improving patient care and experience. 7.Professional Development: Access to advanced training and education opportunities can aid career growth and professional development. 8.Enhanced Skills: Simulation-based training and hands-on experience can improve clinical skills and confidence. 9.Networking Opportunities: Collaboration with peers and experts can foster knowledge sharing and networking. Future Implications: 1.Scalability: This partnership can serve as a model for other healthcare institutions, promoting widespread adoption of innovative training methods. 2.Research and Development: The collaboration can facilitate research and development in healthcare education, leading to new breakthroughs and best practices. 3.Industry Recognition: MedLern and Peerless Hospital can establish themselves as leaders in healthcare training and patient care, attracting top talent and recognition. #HealthcareTraining #MedicalEducation #HealthcareInnovation #PatientCareExcellence #ClinicalExcellence

THIRUVANANTHAPURAM: Sree Chitra Tirunal Institute for Medical Sciences and Technology in Thiruvananthapuram has started a Centre of Excellence dedicated to advancing minimally invasive cardiovascular devices. The centre will focus on the development of devices such as Transcatheter Aortic Valves, Abdominal Aortic Stent Grafts, Clot Retriever for stroke treatment, Patent Ductus Arteriosus Occluder and Peripheral Stents, which will be made ready for early technology transfer. The success of the centre is expected to bring down the cost of these devices which are currently imported. “Minimally invasive therapy can be offered to patients with very high surgical risk and give a fresh lease of life to these otherwise inoperable patients. It has lesser morbidity, and risk of infection, and allows quicker discharge from the hospital. Long term outcome of these devices is similar or better when compared to open heart surgery. The other advantages are a lesser requirement of infrastructure and quick patient turnover time,” said an official statement. With societal changes and the fast life of current and upcoming generations, with less time to rest, cure and care, minimally invasive therapy would be preferred by patients. Centre of Excellence is funded by the Department of Biotechnology, Government of India, and is housed within the Department of Medical Devices Engineering, as part of the Division of Artificial Internal Organs at the Biomedical Technology Wing of SCTIMST. Source: The New Indian Express #healthcarestartup #startupdevice #dseide #startup

Between September 30 and October 30, 2024, as many as 17 startups from diverse sectors raised over $71 million in funding from investors. These sectors include B2B Saas, Healthtech, Sportstech, Wellness, Healthcare, Fintech, Deeptech, Dronetech, and Beauty. Last week, Indian startups raised over $366 million in funding, with SaaS startup Whatfix raising $125 million alone. A diverse range of sectors attracted investments during the week, with Specialty chemical leading the pack. Leading this sector was Mstack, which raised $40 million in a Series A funding round. Fintech startup BASIC Home Loan raised $10.6 million in a Series B round. The list was followed by Sportstech startup Str8bat, Furniture startup Furnishka, and Cancer care startup OnCare, which collectively raised $9.71 million. Str8bat raised $3.5 million, Furnishka raised $3.21 million, and OnCare raised $3 million. Aromatherapy-based wellness startup Secret Alchemist raised the smallest amount, securing $500,000 in a Seed funding round. This was followed by B2B SaaS startup Zintlr raised $890,000 in a Seed funding round. Healthtech startup Ai Health Highway raised $1 million in a pre-Series A round, Dronetech startup IG Drones raised $1 million, Skincare startup Conscious Chemist raised $1.42 million in a funding round, while Electric Mobility startup ZEVO secured $2 million in a pre-Series A funding round. Skincare startup ClayCo Cosmetics raised $2 million in a Series A round. Health & Wellness startup Lissun secured $2.5 million in a pre-Series A funding round. Meanwhile, Defencetech startup Digilogic Systems India, Deeptech accelerator SanchiConnect, Dronetech startup Garuda Aerospace, and Healthtech startup Sugar.fit kept the funding figures under wraps. Source: Indian startup news #healthcarestartup #startupfunding #dseide #startup

India's healthcare sector is rapidly growing, driven by AI and cloud computing advancements. These technologies enhance healthcare delivery, operational efficiency, and patient care, shaping a progressive digital health landscape. In an era where technology intertwines seamlessly with daily operations, the healthcare sector stands out as a prime beneficiary of this digital revolution. With India's healthcare market burgeoning at a rapid pace, the infusion of advanced technologies such as AI and cloud computing is not just an option but a necessity to cater to the growing demands and complexities of modern healthcare. Shailesh Singla, Senior Director of Applications at Oracle, sheds light on how these technologies are not only enhancing the operational efficiencies of healthcare providers but also revolutionizing patient care through personalized, data-driven approaches. The Indian healthcare sector accounts for about $372 billion and is growing at a compounded annual growth rate (CAGR) of 22%. Globally, the size of the sector is $10 trillion. It is benefiting from the increasing adoption of digital technology making healthcare more accessible, secure, reliable, usable and enhancing decision-making and patient care. There’s growing interest in utilising data to improve healthcare processes, with data sharing leading to better insights, enabling disease spread tracking. The pandemic has accelerated this trend, and it is expected to continue, with healthcare organisations increasingly seeking support from technology companies like us. With consolidated patient data, digital health solutions empower healthcare providers to support patients, improve operational performance and offer personalised and proactive care. By analysing vast amounts of patient data, these solutions can predict health trends and records, identify potential risks, and recommend tailored treatment plans. Structured data transforms healthcare delivery from a fragmented system to a seamless experience that results in improved results. With a holistic view of a patient's condition, including medical history, allergies, and current medications, providers can make quicker diagnosis, eliminate redundant tests, and facilitate smoother care transitions. This approach not only improves efficiency but also reduces costs and minimises patient frustration, ultimately leading to better healthcare outcomes. Source: PCQuest #healthcarestartup #dseide #startup #healthcareAI

CureBay is indeed a shining example of a startup scaling up to make a significant impact on healthcare access in rural India. About CureBay CureBay is a healthcare technology startup founded in 2016 with a mission to bridge the healthcare gap in rural India. They aim to provide accessible, affordable, and quality healthcare services to underserved communities. Key Features and Innovations 1.Telemedicine platform: CureBay connects rural patients with urban doctors through video consultations, reducing the need for physical travel. 2.Digital health records: Patients' medical history is stored digitally, ensuring continuity of care. 3.AI-powered diagnostic tools: Supports doctors in diagnosing diseases more accurately. 4.Network of rural health workers: Trained professionals facilitate patient consultations and provide basic medical care. Impact and Achievements: 1.Expanded reach: CureBay has established a presence in over 5,000 villages across India. 2.Patient base: Served over 1 million patients. 3.Partnered with governments: Collaborated with state governments to implement healthcare initiatives. 4.Awards and recognition: Received awards from prominent organizations, including the Indian government. Challenges and Future Directions: 1. Infrastructure: Overcoming connectivity and technology infrastructure challenges in rural areas. 2. Awareness: Educating rural communities about telemedicine benefits. Scaling sustainably: Maintaining quality while expanding services. 3.Integrating AI: Further leveraging AI for predictive analytics and personalized medicine. CureBay's success demonstrates the potential for startups to drive meaningful change in rural healthcare. Their innovative approach and commitment to accessibility have paved the way for others to follow suit. SOURCE- Editorji #HealthcareInnovation , #DigitalHealth , #RuralHealthcare , #HealthcareAcces

Welcome [rmh] , That was amazing to meet you at hospex 2024

The Ministry of Health and Family Welfare has introduced comprehensive regulations for medical devices aimed at aligning the country's regulatory framework with globally accepted standards. This initiative seeks to foster a regulatory ecosystem that promotes growth and innovation in the medical device sector. The Central Drugs Standard Control Organization (CDSCO), under the Ministry of Health and Family Welfare, applied for Affiliate Membership in the International Medical Device Regulators Forum (IMDRF) in 2024. After review of India’s application for Affiliate membership and meeting discussions by the IMDRF Management Committee (MC) with the senior officers of CDSCO during the 26thSession of IMDRF held in September 2024 at Seattle, Washington, USA, the CDSCO has received approval from IMDRF as an Affiliate Member of the Forum. The International Medical Device Regulators Forum (IMDRF), established in 2011, is a collaborative group of global medical device regulators dedicated to accelerating the harmonization and convergence of international medical device regulations. IMDRF members include national regulatory authorities from the US, Australia, Canada, the European Union, Japan, the UK, Brazil, Russia, China, South Korea, Singapore, and the World Health Organization (WHO). Achieving Affiliate Membership in the IMDRF will provide significant opportunities for reliance and collaboration with regulatory authorities around the world. The membership helps to harmonise regulatory requirements across the globe, which reduces the complexity for manufacturers and helps in safeguarding public health by promoting collaboration, harmonizing regulations, and promoting convergence. It also helps to support innovation and timely access to new medical devices. India will participate in IMDRF Open Sessions to have information exchange on technical topics with other regulators, discuss on latest medical device regulatory strategies and trends, provide feedback on India’s experience and perspectives, use IMDRF documents in part or in whole as the basis for India’s regulatory framework for Medical Devices. This will strengthen the CDSCO’s medical device regulatory system, helping meet emerging technical challenges that are increasingly diverse, ensuring the protection of public health and safety, and continuing to maintain the goal of international recognition for its Medical Device regulation. This membership will enable Indian medical device manufacturers to meet the regulatory requirements of IMDRF member countries, thereby strengthening the "Brand India" in the global market. Source: indiamed today #healthcarestartup #dseide #startup

Earlier this week, the death of yet another corporate employee shook the nation. Various other incidents also made headlines last month, where employees of some big companies reportedly died of work pressure. With a rise in such incidents, people are talking about the importance of work-life balance and mental health at workplace. Zoho CEO and Co-founder Sridhar Vembu, in a new interview with PTI, has called for a fundamental shift in how companies treat their employees. In the interview, the entrepreneur warned that organisations pushing their workforce to unsustainable limits will not be able to keep up the pace. He also called for a shift in mindset and said that people are being put in a "very big pressure cooker." Vembu, who has spent over two decades building Zoho into one of India’s leading tech companies, expressed deep concern over the increasing pressure faced by employees, particularly in large cities. He said that we are creating environments where workers are trapped in a ‘pressure cooker’, referring to the convergence of long working hours, grueling commutes, and the isolation many young professionals experience after migrating from smaller towns. You already have loneliness, long-commutes, stressful work condition. So, you are throwing people into a very big pressure cooker, and very tragically, some people break, other people are broken," he told PTI. Reflecting on his own experience, Vembu stressed the importance of pacing oneself in order to sustain a long and productive career. “I have been working for 27-28 years, and I hope to work for another 28 if possible. But to do that, I cannot allow myself, or my employees, to burn out,” he explained. He argued that companies prioritising short-term gains at the expense of their workers’ health are doomed to falter in the long run. Source: Business Insider #healthcarestartup #dseide #startup

The Cancer AI Alliance (CAIA) is a groundbreaking initiative that brings together medical and tech expertise to revolutionize cancer care. With $40 million in funding, this alliance is poised to make a significant impact. The CAIA is a collaboration between top medical institutions specializing in cancer care, including Fred Hutchinson, Johns Hopkins, Dana Farber, and Sloan Kettering. These organizations are joining forces to harness the power of artificial intelligence (AI) in advancing precision medicine . One of the key challenges in cancer research is the difficulty in sharing data between medical organizations due to regulations and technical issues. To overcome this, the CAIA will utilize federated learning, a secure data collaboration method that allows raw data to remain private while still enabling AI training . The alliance has received significant backing from tech giants, including Microsoft, AWS, Nvidia, and Deloitte, which have contributed a mix of operating cash, services, and expertise . This support will enable the CAIA to develop shared infrastructure, standards, and specific goals, such as creating models for drug discovery and diagnostics. The ultimate goal of the CAIA is to accelerate progress in cancer research and improve patient outcomes. By combining the expertise of leading medical institutions with the power of AI, this alliance has the potential to transform the field of oncology and save countless lives . #CancerAIAlliance #CancerResearch #ArtificialIntelligence #AIinHealthcare #PrecisionMedicine #HealthTech

The BioE3 policy! That's an exciting initiative aimed at fostering innovation, collaboration, and entrepreneurship in the biotechnology and bioproducts sector. What is BioE3? BioE3 stands for Biotechnology and Bio-products-based Entrepreneurship and Enterprise Development. It's a policy framework designed to promote the growth of the biotech industry, encourage entrepreneurship, and create a supportive ecosystem for innovative bio-based products and services. Key Objectives: 1.Boost Innovation: Encourage research and development in biotechnology, leading to novel products and services. 2.Foster Collaboration: Promote partnerships among academia, industry, government, and startups to leverage resources and expertise. 3.Enhance Entrepreneurship: Support entrepreneurs and startups in the biotech sector through funding, mentorship, and infrastructure. Strategies: 1.Research Funding: Provide grants and funding for biotech research projects, focusing on areas like healthcare, agriculture, and environmental sustainability. 2.Incubation and Acceleration: Establish bio-incubators and accelerators to provide infrastructure, mentorship, and networking opportunities. 3.Regulatory Support: Streamline regulatory processes to facilitate the commercialization of biotech products. 4. Development: Offer training and education programs to build a skilled workforce in biotechnology. 5.International Collaboration: Encourage global partnerships to access new markets, technologies, and expertise. #BioE3 #Biotechnology #Entrepreneurship #Innovation #Sustainability #BioEntrepreneurship #BiotechPolicy

Meet [Nithinkalarikkal] Happy to connect !

Meet [suraj] 😀 Discover how this innovative startup is revolutionizing the healthcare industry! Don’t miss the chance to engage with their cutting-edge solutions.

Inauguration of HOSPEX Healthcare Expo 2024! 🌟

The Department of Health Research (DHR) has made some exciting progress in supporting startups and developing plans for rare disease drugs in India. One of the key achievements mentioned in their 100-Day Report is the creation of 'Med-Tech Mitra', a platform designed to assist startups and private players in securing clinical validation and upscaling services . This initiative aims to boost innovation and growth in the healthcare sector. In addition to Med-Tech Mitra, the DHR has also implemented the 'National One Health Mission for Pandemic Preparedness' and upgraded six Viral Research and Diagnostic Laboratories (VRDLs) into Integrated Research and Diagnostic Laboratories (IRDLs) to cover a broader range of infectious diseases . When it comes to rare disease drugs, companies like Takeda Biopharmaceuticals India Private Limited are expanding their portfolio in India. They've recently launched Cinryze, an injectable prescription medicine for the treatment of hereditary angioedema (HAE), a rare genetic condition that causes swelling in different parts of the body . There are also various startups focused on developing innovative therapies for rare diseases. Some notable examples include: 1.Entrada Therapeutics, which is developing novel therapeutics for devastating diseases like Duchenne muscular dystrophy (DMD) . 2.Healx, which uses artificial intelligence to analyze medical research data and repurpose existing drugs to treat rare diseases . 3.Passage Bio, a fully integrated gene therapy company developing life-transforming therapies for rare monogenic central nervous system diseases . These developments demonstrate the growing focus on supporting startups and addressing the unmet needs of individuals affected by rare diseases in India. #DHR100DayReport #HealthcareInnovation #StartupsInIndia #RareDiseaseAwareness #OrphanDrugs #MedTechMitra #NationalOneHealthMission #PandemicPreparedness #HealthcareTransformations #IndiaHealthcare #Biotechnology #PharmaceuticalAdvancements #RareDiseaseTreatment #HealthResearch #HereditaryAngioedema (HAE) #DuchenneMuscularDystrophy (DMD) #GeneTherapy #RareGeneticDisorders SOURCE- ET Healthworld from Economic Times

Be a part of this transformative journey with DSEIDE at Hospex 2024. 🌟

The World Health Organization recognises health financing as a “core function of health systems that can enable progress towards universal health coverage by improving effective service coverage and financial protection.” For a significant part of the Indian population, this is crucial given the rural-urban healthcare divide, the prevalence of low and middle-income groups, and the general lack of awareness about health concerns. These factors compromise our healthcare infrastructure and delivery. Despite the notable evolution of our healthcare system, providers are yet to realise their true potential as global leaders. Healthcare financing can fuel their efforts with a multifaceted approach to provision, management, and accessibility for India's vast and diverse population. The healthcare finance arsenal is designed to enable organisations to meet every person's needs and achieve positive patient outcomes. Proper and informed financial planning promotes operational efficiency, ensuring smooth day-to-day functioning, preparedness for unforeseen circumstances (highlighted by the COVID-19 pandemic), and adherence to regulatory parameters. Private equity (PE) investments play a critical role in Indian healthcare. Hospital owners or promoters often opt for PE investments instead of accumulating more debt. PE investors aim to enhance financial performance by curbing expenses, enhancing service quality, boosting sales, and embracing technological advances, collectively improving the company's profit and loss statement and strengthening its balance sheet. Substantial progress has been made in recognising changing healthcare priorities, as outlined in the National Health Policy of 2017. The policy aims for the highest possible level of health and well-being for all through a preventive and promotive healthcare orientation in all developmental policies. It emphasises professional standards, reducing inequity, ensuring universality, patient-centred quality care, financial and performance accountability, and adapting healthcare organisations based on new knowledge and evidence. Source: Healthcare World #healthcarestartup #startup

Indian startup Qure.AI raised $65 million from investors led by Lightspeed Venture Partners and 360 ONE Asset Management, gaining funds to expand and develop its products that use artificial intelligence to help detect diseases. Merck & Co.’s Merck Global Health Innovation Fund and Kae Capital joined the Series D round, along with existing investors including Novo Holdings, Health Quad, and TeamFund, the startup said Monday in a statement. It plans to use the proceeds to expand in the US and other markets, improve its generative AI foundation models and fund acquisitions. The Mumbai-based startup’s products use AI to help identify and manage critical diseases at more than 3,000 imaging sites in over 90 countries. The company, founded in 2016, says its solutions outdo human radiologists and physicians in diagnosing conditions like tuberculosis, lung cancer and stroke. Several of its products are cleared for use by US and European Union regulators. AI is helping overcome health care bottlenecks, said Prashant Warier, Qure.AI’s co-founder and chief executive officer. The technology is increasingly being used in areas such as drug discovery, patient management in hospitals and surgical robots. Source: The Economic Times #healthcarestartup #startup

Indian companies are stepping up their employee benefits game, particularly when it comes to health and wellness initiatives. This shift is largely driven by the growing recognition of the importance of employee well-being for organizational success . The Indian health and wellness market, valued at nearly $78 billion in 2020, is expected to experience significant growth, reaching $1,299.84 billion by 2024 . Key Areas of Focus: 1.Holistic Wellness Programs: Companies are adopting comprehensive wellness programs that cover physical, mental, and emotional well-being . 2.Personalized Plans: Employees are being offered tailored wellness initiatives, including personalized coaching and adaptable programs . 3.Technology Integration: Wellness companies are leveraging apps, portals, and virtual platforms to engage employees, track goals, and provide remote services . 4.Mental Health Support: Initiatives focused on stress management, meditation, and mental wellness are gaining traction . By prioritizing employee well-being, Indian companies can expect benefits such as improved productivity, reduced healthcare costs, and enhanced employee engagement and morale . SOURCE- The Economic Times #EmployeeWellness #HealthAndWellness #CorporateWellness #EmployeeBenefits #HealthIndia

The much awaited International Startup Festival (ISF) is back. The ISF has grown bigger with every passing year. The second edition of ISF, which was held in Bangalore last year, witnessed participation of more than 30 speakers, 500 venture capitalists, HNIs, angel investors, over 100 CEOs and CXOs, and 10,000 startups. The third edition, scheduled to be held during September 26-28, 2024, in Hyderabad, is going to attract 50,000 startups, 2,000 exhibitors, 250 CXOs, 300 VCs, 800 global angels, and 5,000 delegates from 15 countries. ISF-2024, organised by International Startup Foundation, is the brainchild of a visionary leader, serial entrepreneur and a multifaceted person, JA Chowdary. He has successfully helmed vital roles including that of Founding Director of Software Technologies Parks of India, Chief Architect of Hi-Tec City in Hyderabad, Founding member of PortalPlayer, Co-founder of TalentSprint, and Chairman of India Blockchain Technology Standards Committee. In an interview, JA Chowdary, well known as JA, shares insights about the changing technology landscape and India’s thriving startup ecosystem. Last year’s International Startup Festival focused on rural economy as we had noticed that startups have wide scope in solving real problems of rural India. This year’s conference is focused on how AI can be useful for startups to come up with new products or solutions quickly. Earlier, in the absence of AI tools developing a solution would take lot of time. Today with a prompting technology, developing a solution, time to market, idea to realisation gets fastracked which increases chances of survival of the startup. Hence, this year, ISF will focus on three Ms, which is, money, mentorship and marketing for early and growth stage startups. This year, 50,000 startups have registered of which 150 will participate in the Demo Day. These startups will be segregated based on the sector they operate in for networking with those sector specific investors. Out of the 150, 15 to 20 startups will be selected to present their solution and pain-points in front of ISF’s network of 550 global investors and mentors from North America, Europe, Singapore and India, every Saturday. During last year’s edition held in Bangalore, investors signed 150 term sheets. We do not want to put a tab on the number of term sheets that will be signed this year, but what I can say is that today, ISF angels have already committed Rs250 crore. Source: Hans India #healthcarestartup #startup

Startups raised around $587.9 million between September 14 and 20, marking a 232.2% increase compared to the same period last year. This also represents a 358.1% rise from the previous week’s $128.3 million. This week, startups raised funding through 24 rounds compared to 28 in the year-ago period, when they raised a total of $177 million, according to data from data intelligence platform Tracxn. Edtech unicorn PhysicsWallah’s $210 million funding round was the largest this week. This week’s ETtech Deals Digest revealed a significant rise in startup funding, surging by 232% year-over-year to $588 million. The data, compiled by startup intelligence platform Tracxn, shows that this funding was raised through 24 rounds, compared to 28 rounds in the same period last year. Despite fewer deals, the total amount raised was substantially higher, marking a shift in the market's investment climate​. Key Highlights and Major Deals: PhysicsWallah: The largest contributor to this week's funding surge is the edtech giant PhysicsWallah, which secured a remarkable $210 million. This round of funding valued the company at $2.8 billion, positioning it as one of the leading players in the edtech sector. PhysicsWallah’s success highlights the continued investor confidence in the education technology space, which has seen accelerated growth due to the COVID-19 pandemic, changing educational dynamics worldwide. PhysicsWallah's rise is particularly noteworthy because it reflects the increasing demand for digital education platforms. With more students and institutions transitioning to online learning, platforms like PhysicsWallah are becoming integral to the education ecosystem. This round of funding will likely be used to expand the company’s services, improve technological infrastructure, and perhaps fuel international growth. Nazara Technologies: Another standout in this week's funding activity is Nazara Technologies, a gaming and media company that raised $107.8 million. Nazara has built a diverse portfolio in gaming and interactive entertainment, tapping into sectors like esports, mobile gaming, and gamified learning platforms. The company’s success in securing this substantial funding indicates the growing significance of the gaming industry in India, a sector that has seen immense growth in recent years, partly driven by increased internet penetration and a young, tech-savvy population. The gaming industry has been booming globally, and Nazara's success in securing capital underscores the immense potential seen by investors in this space. With the gaming sector projected to grow even further, investments like these are expected to drive innovation and increase competition within the market. M2P Fintech: Fintech continues to attract investor attention, and M2P Fintech raised $50 million in this week’s rounds. The company's innovative approach to financial services has made it an attractive investment. M2P Fintech provides API infrastructure for banks and other financial institutions, offering solutions across a range of services like payments, lending, and card issuance. This investment signifies the growing reliance on financial technology in a world where digital transactions are becoming increasingly important. Fintech startups like M2P are playing a pivotal role in shaping the future of finance by making it more accessible, efficient, and user-friendly. Redcliffe Labs: Redcliffe Labs, a healthtech startup, secured $42 million in its Series C round. This funding comes at a time when healthcare is undergoing a rapid transformation with technology playing a crucial role in diagnostics, patient management, and treatment. Redcliffe Labs focuses on diagnostics and is known for its wide range of health test offerings, both at-home and in clinical settings. The healthtech sector is increasingly seen as one of the most promising fields for investment, especially after the COVID-19 pandemic underscored the need for better diagnostic and healthcare solutions. Redcliffe Labs' ability to raise such a significant amount reflects the growing investor confidence in the future of health technologies that simplify and improve healthcare delivery. Other Funding Rounds: While the deals mentioned above were the highlights, several other startups also made their mark. For instance, companies in sectors like SaaS (Software-as-a-Service), enterprise solutions, and consumer tech also attracted funding. This broad-based interest across sectors indicates that investors are not focusing on a single domain but are instead betting on innovation across multiple industries. Market Implications: This sharp increase in funding reflects a strong recovery in the startup ecosystem, which had been somewhat dampened in previous months due to macroeconomic challenges such as rising interest rates, inflation, and global economic uncertainty. The return of investor confidence, demonstrated by these large funding rounds, suggests that investors are once again eager to pour capital into promising startups, particularly in sectors like edtech, fintech, gaming, and healthtech. Additionally, the trends point to a selective approach by investors who are focusing on scaling up businesses with proven models rather than early-stage startups. Established companies like PhysicsWallah and Nazara Technologies are attracting more significant investments, indicating that investors are looking for stability and growth potential in an otherwise volatile economic landscape. Source: The Economic Times #healthcarestartup #startup #funding

GS1 India, a supply chain standards organisation set up under the Ministry of Commerce, Government of India, hosted the ‘Navigating the Future of Healthcare: From Vision to Reality’ conference at the India Habitat Centre, New Delhi. The event brought together 150+ participants including healthcare experts, government officials, pharmaceutical manufacturers, and industry leaders. The conference aimed to serve as a platform for the stakeholders to discuss strategies for enhancing healthcare delivery through standardised practices. During the keynote address, S Swaminathan, CEO, GS1 India, emphasised the importance of collaboration among healthcare stakeholders to improve patient outcomes. “It is time for all healthcare providers and supply chain partners to align their efforts towards the well-being of our citizens,” he stated. Swaminathan highlighted how breakthrough innovations, including AI and 2D barcodes, are revolutionising healthcare processes and ensuring product authenticity and safety. Vinod Kotwal, Member Secretary, NPPA, emphasised the need for product and product data enabling the vision of enhanced patient safety. She also discussed that technology must be harnessed to overcome supply chain challenges. Chandrashekar Ranga, Joint Drugs Controller (India) CDSCO, suggested that the need of the hour is global harmonisation in the healthcare sector and asserted that a simple barcode scan is needed to ensure unique identification of products which helps in the detection of falsified medicines and drug recall. Dr Upasana Arora, MD, Yashoda Super Speciality Hospitals, conveyed that barcodes are essential for ensuring uncompromised patient safety. She advocated for the adoption of digitisation, highlighting the growing prevalence of robotics, patient portals, and e-ICUs. Dr Sunil K Khetarpal, Director, AHPI, further asserted that patient-centric digital health initiatives should be undertaken to enable accessibility, affordability, acceptability, and availability. Several industry experts discussed the ‘Role of AI in Healthcare: AI-Driven Proactive Care and Predictive Intervention.’ They explored the impact of AI on preventive care, diagnosis, and treatment alongside its regulatory aspects. The first panel discussion of the conference explored the scope of ‘Enhancing Drug/Medical Device Supply Chain Security through End-to-End Traceability.’ The panellists deliberated how end-to-end supply chain traceability can mitigate risks, enhance product recalls, and ensure regulatory compliance in the medical device industry. In the session focused on ‘Role of Standardisation and Interoperability in Drug/Medical Device Registry Design, it was discussed how registries are key to managing healthcare data, enabling interoperability, and enhancing supply chain transparency. The panellists dissected their role in supporting efficient insurance claims and personalised medicine. In their presentation, experts from USAID Lindabeth Doby, Rachel Smith, and Beth Anne Cusack underscored the need for ‘Global Harmonisation in the Healthcare Landscape.’ Another group of panelists discussed ‘Leveraging GS1 Standards for a Resilient Healthcare Supply Chain.’ They uncovered the benefits of interoperable 2D barcodes and standards in the healthcare supply chain. Later in the conference, Senthil Rajaratnam, Director, Eli Lilly, conducted a knowledge session on the ‘Impact of Standards and Case Studies of Successful Implementations.’ During the session, he outlined regulatory requirements for barcodes on drug packaging, shared successful case studies, and offered recommendations for the industry. Geraldine Lissalde Bonnet, Vice President -Healthcare, GS1 Global, also spoke about ‘Navigating Regulatory Challenges in a Rapidly Evolving Pharma Landscape.’ She discussed the evolving global regulations and highlighted their impact on the industry. The key speakers at the event also explored the regulatory landscape, including the recent mandates for QR codes on pharmaceuticals and their role in ensuring compliance and supply chain transparency. GS1 India invited stakeholders from the healthcare ecosystem to facilitate collaboration and drive innovation in the industry. The conference enabled industry players to engage with solution providers and enhance their healthcare delivery. The conference concluded with a presentation on ‘Enhancing Patient Care with Medical Devices,’ featuring insights on the application of barcodes in detecting and reducing medical devices’ adverse events. Source: Express Pharma #healthcarestartup #startup #funding

When it comes to healthcare startups approaching employers, there are several key strategies to keep in mind: Know Your Worth Healthcare companies need to be confident in their offerings and understand their value proposition. This means having a clear understanding of the problems they're trying to solve and the solutions they provide . Identify the Problem You're Trying to Solve Startups need to pinpoint the specific challenges they're addressing and develop targeted solutions. This involves researching the needs of potential employer clients and understanding their pain points . Josh Sturm, Chief Revenue Officer of Color Health, suggests that startups should collaborate with employers to gain a deeper understanding of their needs . Find the Right Employer Channel It's crucial to identify the right channels to reach employers. This might involve working with large employers, mid-sized businesses, or specific industry sectors . Jim Winkler, Chief Strategy Officer of Business Group on Health, notes that startups should consider the global reach of potential employer clients . Think Globally Healthcare challenges are often global issues, and startups should be prepared to address these broader needs. This might involve adapting solutions for international markets or partnering with global healthcare organizations . Focus on Employee Engagement Employers are looking for innovative solutions that prioritize employee engagement and well-being. Startups should focus on developing solutions that meet employees where they are, whether through digital platforms, wellness programs, or personalized healthcare services . By following these strategies, healthcare startups can effectively approach employers and establish successful partnerships. SOURCE- MedCityNews #EmployerSolutions #HealthcareSolutions #DigitalHealth #HealthcareDisruption #WellnessAtWork #EmployeeEngagement

Climate tech startup ecosystem, represented by over 800 operational climate tech startups, has raised over $3.6 billion between 2014 and 2024. Less than 3 per cent of startups have been able to reach Series B or beyond funding levels in India’s climate tech ecosystem which addresses critical challenges in the world’s 7th most vulnerable country to both the causes and impacts of climate change, said a report on Friday. Innovation for Impact: Indian Startups Driving Climate Action report by IIM A Ventures and Japan’s MUFG Bank said that while early-stage funding is relatively robust with two-thirds of funded startups securing seed rounds, there’s a noticeable gap in growth-stage capital. “This indicates a need for more substantial later-stage investments to help promising solutions scale,” the report said for the climate tech startup ecosystem represented by over 800 operational climate tech startups and over $3.6 billion raised between 2014 and 2024. “India’s climate tech sector is not just a rapidly growing industry but a vital force in the global fight against climate change. The $3.6 billion raised by startups over the past decade highlights the sector’s significant potential and the pressing need for enhanced support to scale breakthrough solutions,” Chintan Antani, IIMA Ventures. The report further noted that over 80 per cent of climate tech startups are focusing on emission-reducing (mitigation) solutions, while solutions for building resilience are relatively sparse. In terms of funding, transport and mobility startups dominate the climate tech ecosystem with over 350 startups raising nearly 85 per cent of the total funding. “However, other sectors like industrial decarbonization, waste management & circularity, and alternative fuels remain underfunded despite their high potential for climate impact,” the report said. Source: Financial Express #healthcarestartup #startup #funding

Midi Health, a startup providing menopause care, has just secured a $5 million fundraising boost from a star-studded lineup of investors, including celebrities, CEOs, and sports stars. This impressive list of backers features big names like Amy Schumer, Alysia Reiner, and Brandi Chastain, alongside top executives from companies like Meta, Stripe, and Cloudflare . Midi Health's innovative approach to menopause care has clearly resonated with these influential investors. The startup offers comprehensive, evidence-based medical care, addressing a wide range of symptoms associated with perimenopause and menopause, from hot flashes to depression and anxiety . With virtual appointments and a network of doctors and NPs, Midi Health is making quality care more accessible to women across the US. This $5 million fundraising round is just the latest milestone in Midi Health's remarkable growth journey. The company has already secured $100 million in funding to date, with notable investors like GV (Google Ventures), Emerson Collective, and Memorial Hermitt . With this fresh influx of capital, Midi Health plans to expand its insurance coverage, hire more clinicians, and diversify its service lines to support even more women . It's exciting to see Midi Health's mission gaining traction and support from such a diverse range of investors. As the global women's healthcare market continues to grow – projected to reach $17.8 billion by 2024 – startups like Midi Health are poised to make a real impact on women's lives. SOURCE- FORTUNE #MidiHealth #MenopauseCare #WomenHealth #HealthTech #StartupFunding #WomenLedStartups

Early-stage investment firm z21 Ventures, which backs technology startups in India and those founded by Indian-origin entrepreneurs in the US, has raised $20 million in the first close of its $40 million second fund with investment firm WestBridge Capital joining as anchor investor. Fund II will continue to support tech firms across sectors such as artificial intelligence, enterprise software and healthcare. The fund will mainly consider pre-seed and seed-stage investments, focusing on startups with strong teams, innovative technologies, and large market opportunities, according to California-based z21 Ventures. Founded in 2022 by healthcare focused software-as-a-service (SaaS) unicorn Innovaccer cofounder and CEO Abhinav Shashank and former Innovaccer executive Raj Shekhar Singh, z21 Ventures runs as a collective of Indian-origin tech executives in the US. These executives, who serve as limited partners (LPs) or sponsors, include those from companies like Innovaccer, Nutanix, Google, Cisco, Apple, Amazon, and Meta. "We are thrilled to announce the first close of our fund II and welcome WestBridge Capital as our anchor investor," said Singh, cofounder and managing partner of z21 Ventures. "This successful fundraise is a validation of our community led model and our track record of identifying and supporting promising early-stage companies.” The announcement follows the complete deployment of z21’s $5 million maiden fund this June, which backed 26 startups. Portfolio firms include Fireside Ventures-backed medical device startup Inito, Peak XV Partners-backed AI firm Truefoundry, and Y Combinator-backed restaurant management software startup Explorex. The second fund will consider raising more capital from leading operators and experts who will mentor and support founders, according to the statement. "z21 Ventures is well-positioned to succeed, and their community-focused and operator-led model can provide valuable support for early-stage founders and help build category-defining companies," said Sumir Chadha, cofounder and managing partner at WestBridge Capital. Source: The Economic Times #healthcarestartup #startup #funding

Goa Chief Minister Pramod Sawant has launched the Goa University Research Park Unit (GURU) initiative to boost innovation and start-ups in the biotech and tech sectors . This initiative is part of the UniGoa Knowledge and Innovation Foundation and has received an investment of Rs 12.85 crore to establish state-of-the-art facilities and equipment . The GURU initiative aims to support young innovators in various fields, including biotechnology, healthcare, information technology, and electronics ¹. It's expected to play a pivotal role in nurturing young innovators and incubating start-ups in bio-engineering, agriculture, healthcare, and electronics, contributing significantly to society. Key Focus Areas of the GURU Initiative: 1.Biotechnology: Supporting start-ups and innovators in biotechnology research and development. 2.Healthcare: Encouraging innovation in healthcare services and technology. 3.Information Technology: Fostering growth in IT start-ups and entrepreneurship. 4.Electronics: Promoting innovation in electronics manufacturing and research . This initiative is a significant step towards promoting innovation and entrepreneurship in Goa, and we can expect to see exciting developments in the biotech and tech sectors in the coming years! SOURCE- THE HINDU #GURUInitiative #GoaInnovates #StartUpGoa #BiotechRevolution #TechForTomorrow #InnovationHubGoa

Three months ago, startup Hippocratic AI released its first commercial product, a generative AI-based, task-specific healthcare agent. It also unveiled a collaboration with Nvidia in March to develop large language models for healthcare. The AI chipmaker has now progressed from being a partner to an investor. Nvidia's venture capital arm, NVentures, along with Greycroft and Lee Shapiro of 7Wire Ventures, backed a $17 million investment as an add-on to Hippocratic AI's recently closed extended Series A round. The startup has raised $137 million to date, after banking $53 million in series A funding in March. The first close of the Series A round was co-led by Premji Invest and General Catalyst with participation from SV Angel and Memorial Hermann Health System as well as existing investors Andreessen Horowitz (a16z) Bio + Health, Cincinnati Children’s, WellSpan Health, and Universal Health Services (UHS). That series A round boosted Hippocratic AI's valuation to $500 million. “Generative AI will expand the healthcare industry and its ability to serve the growing demands of patient care, and Hippocratic AI is putting the technology to work to increase access to healthcare,” said Kimberly Powell, vice president of healthcare at Nvidia in a statement. “The company’s safety-focused approach uses advanced Nvidia technologies to make personalized, real-time patient interactions more natural and capable, helping build trust among patients and clinicians alike.” Munjal Shah, a serial entrepreneur, founded Hippocratic AI along with a group of physicians, hospital administrators, healthcare professionals and artificial intelligence researchers from El Camino Health, Johns Hopkins, Washington University in St. Louis, Stanford, Google, and Nvidia. "I think this marks the first healthcare investment Nvidia has made that's not a biotech or a pharma investment. We partnered with them five months ago to really bring generative AI to healthcare. It can have a very big impact on healthcare, but they wanted to ensure it was safe, and that's why they partnered with us," Shah told Fierce Healthcare in an interview. Source : Fierce Healthcare #healthcarestartup #startup #funding

part of the prestigious Hospex India Healthcare Expo 2024 as a Healthcare Community Enabler Being listed alongside industry giants and esteemed organizations such as the Kerala Startup Mission ,Indian Society of Anaesthesiologists, AIMED, and other renowned names is a huge honor for us. This recognition highlights Dseide Healthcare Network's growing influence and commitment to transforming the healthcare landscape by connecting professionals, startups, and innovators. 💡

"A $7 Billion Surge: The Evolution of India’s Healthtech Sector Since 2014:" According to Inc42’s ‘The State Of Indian Startup Ecosystem Report‘, healthtech startups raised a little over $7 Bn between 2014 and H1 2024 in 886 deals. In comparison, the cumulative funding raised by Indian startups during this period crossed the $150 Bn mark across 10,500 deals. While ecommerce emerged as the most funded sector with $34 Bn raised across 1,835 deals, fintech took the second spot with $29 Bn in 1,570 deals. Now back to the funding woes of the Indian healthtech paradigm, on a sub-sectoral level, online pharmacy startups led the charts with $1.7 Bn in total funding. Following its lead were fitness and wellness, as well as telemedicine sub-sectors, which cumulatively raised $1.2 Bn in funding in 202 and 186 deals, respectively. On the contrary, while tracing the Indian healthtech funding trends, we observed that investments in the space saw a steep jump during the pandemic. Healthtech funding surged 4.8X from $456 Mn in 2020 to $2.19 Bn in 2021. It is also imperative to mention that the Indian healthtech sector netted a mere $3 Bn in funding between 2014 and 2020. Post the pandemic boom, funding numbers dipped by 19% CAGR every year between 2022-H1 2024. Such was the impact of the capital drought that many startups have had to shut shop. #HealthtechIndia #HealthcareInnovation #TechInHealthcare #DigitalHealthIndia #HealthtechRevolution #StartupFunding #HealthtechStartups #HealthcareTransformation #MedTech #IndianHealthcare #TechForGood #HealthReboot SOURCE- Inc42 Media

As we increasingly live digitally, the intersection of health, fitness, and innovation has become more relevant than ever. One of the most prominent voices in this space, Jitendra Chouksey, Founder of the fitness-tech startup Fittr, is set to take the stage at the ET Soonicorns Summit 2024. Known for his inspiring entrepreneurial journey and fitness achievements, Chouksey will engage in a Fireside chat titled ‘Survival of the Fittest: Secrets of Navigating Fitness-Tech and Building a Strong Business Core.’ The session will explore how startups in the fitness-tech space can thrive in India’s evolving digital economy. From Bhopal to Pune, from working out to running a startup Jitendra Chouksey’s story is nothing short of an exercise in strength, determination, and strategic thinking. Starting his body-building journey at the age of 14 in a small town near Bhopal, Chouksey transformed his passion for fitness into a thriving startup. Now at the helm of Fittr, he has led the company to raise an impressive ₹28 crore from Zerodha-backed VC fund Rainmatter earlier this year. A self-described “accidental entrepreneur,” Chouksey has built an empire that merges fitness and technology, making health and wellness more accessible to Indians. His mission? To make 50 million people fit. Source: The Economic Times #healthcarestartup #startup #innovation

The DBT-BIRAC (Department of Biotechnology - Biotechnology Industry Research Assistance Council) and BFI (Bill & Melinda Gates Foundation India) partnership is a pivotal development in India's biotechnology and healthcare innovation landscape. This collaboration is designed to create an enabling environment for emerging biomedical startups and to accelerate cutting-edge biomedical research. The agreement focuses on key areas such as affordable healthcare technologies, diagnostics, vaccines, therapeutics, and other life sciences-related innovations that can address pressing public health challenges. Key Highlights of the DBT-BIRAC and BFI Partnership: 1. Support for Startups: The collaboration will provide financial assistance, technical mentorship, and infrastructure support to Indian startups working in biotechnology, biomedical engineering, and healthcare innovation. By tapping into the existing ecosystem and providing crucial funding, this initiative will enable startups to overcome early-stage hurdles, such as access to capital and resources. 2. Encouraging Public Health Innovations: One of the goals is to focus on public health challenges that disproportionately affect low- and middle-income populations. The partnership will look at innovations that have the potential to create affordable and accessible healthcare solutions for conditions like infectious diseases, maternal and child health, non-communicable diseases, and nutritional deficiencies. 3.Funding Mechanisms: The pact will involve various funding programs, grants, and accelerator initiatives, enabling startups and researchers to take their ideas from the lab to the marketplace. Through funding schemes like Innovate in India (i3) Fund and Grand Challenges India, the initiative seeks to create a vibrant pipeline for healthcare products and services. 4.Collaborative Research: The partnership emphasizes collaboration between academia, research institutions, startups, and industry stakeholders. This cross-sectoral engagement will help align academic research with market needs, promoting the translation of scientific findings into commercially viable healthcare products. 5.Long-term Vision: Both DBT-BIRAC and BFI have a shared vision of improving healthcare accessibility and quality of life in India, especially in underserved and rural regions. By fostering a conducive ecosystem for biomedical research and startups, the partnership aims to deliver impactful healthcare solutions that cater to the masses. Impact on the Indian Healthcare Ecosystem: 1.Scaling Innovations: Startups backed by this initiative will have the opportunity to scale up their innovations, making them available to larger populations, both within India and globally. 2.Global Collaboration: By working with a globally recognized entity like the Bill & Melinda Gates Foundation, Indian startups and researchers will gain access to international expertise, resources, and networks. 3.Encouraging Social Impact: The focus on affordable healthcare ensures that innovations benefit underserved communities and address critical issues such as infant mortality, maternal health, and diseases that disproportionately affect low-income populations. #DBT #BIRAC #BFI #BiotechInnovation #BiomedicalResearch #HealthcareStartups #BiotechStartups #InnovationInHealth #PublicHealth #AffordableHealthcare #BiotechFunding #HealthcareInnovation #IndianStartups #LifeSciences #ResearchAndDevelopment #BiotechIndia. SOURCE- Healthworld From Economic times

Online travel platform EaseMyTrip announced its foray into the rapidly growing medical tourism sector with the acquisition of significant stakes in two healthcare companies. The company’s board has approved acquisitions worth Rs 90 crore, including a 49% equity stake in Dubai-based Pflege Home Healthcare for Rs 30 crore and a 30% stake in Rollins International for Rs 60 crore. These strategic acquisitions mark EaseMyTrip’s diversification into the healthcare and wellness industry, aiming to cater to the rising demand for medical tourism. EaseMyTrip’s acquisition of a 49% stake in Pflege Home Healthcare for Rs 30 crore signifies the travel platform’s first step into the healthcare services sector. Pflege, based in Dubai, is renowned for its comprehensive range of home-based medical care services, including doctor visits, nursing care, physiotherapy, and critical medical equipment like ventilators and oxygen. This patient-centric approach will now be incorporated into EaseMyTrip’s offerings, providing customers with seamless access to medical treatments abroad, particularly in Dubai, a prominent hub for global medical tourism. Commenting on the acquisition, Nishant Pitti, CEO and co-founder of EaseMyTrip, said, “Our portfolio has expanded significantly with the inclusion of Rollins International and Pflege Home Healthcare. This move allows us to revolutionise medical tourism, making it more accessible and convenient for our customers. Whether for medical treatment or wellness retreats, we are committed to providing seamless, high-quality care to both domestic and international travellers.” EaseMyTrip has also strengthened its presence in the wellness sector by acquiring a 30% stake in Rollins International for Rs 60 crore. Rollins specialises in gluten-free, lactose-free, and allergen-free food products, as well as health supplements and modern wellness therapies. With wellness centres in key Indian cities like New Delhi, Mumbai, Bengaluru, and Hyderabad, Rollins is expected to expand further, allowing EaseMyTrip to cater to health-conscious travellers who prioritize wellness and dietary requirements during their travels. Rohan Jain, co-founder of Rollins International, expressed excitement about the collaboration, stating, “We are thrilled to partner with EaseMyTrip, combining our focus on wellness and allergen-free products with their expansive travel network. Together, we will provide health-focused travel experiences that meet the evolving lifestyle needs of today’s travellers.” Source: Startup Story #healthcarestartup #startup #ventures

AltiusHub, a startup that helps manufacturing companies monitor their supply chain, has raised $2.25 million in a seed funding round led by Endiya Partners. The round saw additional backing from friends and family. The funds will be used to strengthen AltiusHub's engineering team and hire senior talent in specific sectors. The company helps manufacturers secure their supply chain. It caters to sectors such as life sciences, defence, fine chemicals, and luxury goods, which need strong supply chain systems and effective anti-counterfeiting solutions. For instance, in the pharmaceutical sector, its platform prevents counterfeit drugs from infiltrating the supply chain. “AltiusHub was born out of a deep-seated concern with the vulnerabilities in traditional supply chains. We saw firsthand the devastating consequences of counterfeit products, particularly in industries like pharmaceuticals," said Abiram Vijaykumar, Co-founder, AltiusHub. "Our vision is to create a technology that would not only enhance supply chain visibility but also provide a proactive defence against counterfeit threats,” he added. The startup was founded in 2023 in Hyderabad by Siddharth Reddy and Vijaykumar. Ticket9 secures funds from from actress Nayanthara and film director Vignesh Shivan Event tech startup Ticket9 has secured an undisclosed amount in funding from actress Nayanthara and film director Vignesh Shivan. They will join the company as strategic investors. The company had previously raised $200K in a pre-seed round from prominent investors. The new funding will be used to enhance Ticket9's technological infrastructure and expand its market presence. “Ticket9 is well on its way to becoming a dynamic player in the events and entertainment space, and I have no doubt it will grow into a unicorn. I truly believe in its potential, and together we can soar with this user-friendly platform, making a significant impact in both the entertainment industry and the event space,” said Shivan. Founded by Yazhini Shanmugam and Santhos Premraj, Ticket9,is an event tech startup which offers a SaaS platform designed to help organisers create, manage, promote, and monetise events of any scale. Source: YourStory #healthcarestartup #startup #funding

In a world where innovation drives progress, healthcare remains one of the most critical areas requiring constant evolution. From the advent of anesthesia in dentistry to the leaps in medical imaging, technological advancements have redefined patient care and treatment outcomes. Yet, the process of fostering such innovation, especially in public healthcare, is often overlooked. For the past two years, I have been on a unique journey to establish the first public hospital-based medical incubator in Uttar Pradesh, at the Government Institute of Medical Sciences (GIMS), Greater Noida. This incubator aims to transform the future of healthcare by merging clinical expertise with technological advancement, offering trail testing, validation, and much more. At the heart of this project is the belief that public hospitals can and should play a central role in driving healthcare innovation. Historically, much of medical innovation has emerged from private sectors, but public hospitals offer a critical advantage—access to a vast, diverse patient population and clinical expertise from hundreds of doctors and medical professionals. Our incubator at GIMS brings together over 200 clinicians and resident doctors, making it a powerhouse of clinical knowledge ready to collaborate with startups and innovators. The incubator isn’t just a place for technology testing; it’s an ecosystem where healthcare providers and innovators work hand-in-hand to develop solutions that address real-world problems. By bridging the gap between innovation and healthcare delivery, we’re creating an environment where innovation is validated through practical application, ensuring that the solutions being developed are not just theoretical but truly patient-centric. The journey has been anything but easy. For the past two years, I’ve pitched the concept of this incubator to a wide array of stakeholders, from institutional incubators and government bodies to investors and fellow medical professionals. The challenge is multi-faceted. Convincing traditional investors that a public hospital can be a breeding ground for ground-breaking innovation requires not only a solid pitch but also a shift in mindset. Public institutions often face scepticism when it comes to innovation. There’s a misconception that public hospitals, especially in India, are bogged down by bureaucracy and inefficiency, unable to move at the pace that innovation demands. My role has been to break down these stereotypes, to showcase the untapped potential that exists in a public healthcare system where hundreds of clinicians and a diverse patient population are involved daily in addressing complex medical issues. Source:StartupStory #healthcarestartup #startup

It's happening finally ?join us at HOSPEX India

Exciting News ! Dseide has officially partnered with **HOSPEX 2024**, Kerala’s first and only hospital expo! ? Join us on **September 27th-29th** in Kochi for the ultimate showcase of **cutting-edge medical technology**, live demos, startup pitches, and industry networking. This is your chance to explore the future of healthcare and connect with top decision-makers, doctors, and investors. Get ready for a game-changing event! ? Stay tuned for more details! Join the healthcare community to know more about it? https://app.dseide.com/groups/HealthcareStartupHub #HOSPEX2024 #HealthcareInnovation #Dseide

"Reactive Robotics Secures €5M Funding for AI-Powered Healthcare Solutions:" Reactive Robotics, a Munich-based healthcare startup, has just secured €5 million in funding to expand its AI and robot-assisted mobilization in healthcare . This investment is a huge boost to the company's mission to transform healthcare by integrating advanced technology with medical expertise. Founded in 2015, Reactive Robotics has already made significant strides with its assistive robotic system, VEMOTION, which has mobilized over 5,000 seriously ill and intensive care patients, helping them recover faster and reducing the physical strain on nursing and therapy staff . The funds will be used to advance the development of VEMOTION, enabling practitioners to gain enhanced support through data-driven insights. This is especially important in addressing staff shortages and easing workloads in hospitals . With this investment, Reactive Robotics plans to continue its targeted national and international market expansion, making its innovative technology accessible to more healthcare providers and patients. It's worth noting that Reactive Robotics is not alone in the European AI and robotics healthcare space. Other companies, such as Microsure and Quantum Systems, are also making significant advancements in medical technology . However, Reactive Robotics' focus on AI and robot-assisted mobilization sets it apart, and this funding will likely propel the company to new heights. SOURCE-Silicon Canals #DigitalHealth #StartupFunding #VCInvestment #RehabilitationRobotics #AssistiveTechnology #MedicalRobotics #HealthcareTechnology #AIinHealthcare

Amazon Web Services (AWS) has selected seven Indian startups specializing in generative AI for its Global Generative AI Accelerator program. Out of 80 companies selected globally, these seven Indian startups—Convrse, House of Models, Neural Garage, Orbo.ai, Phot.ai, Unscript AI, and Zocket—represent some of the most promising AI-driven businesses. Notably, India’s cohort is also the highest number of startups selected from any Asia-Pacific country, highlighting the nation's growing influence in the AI industry. As part of the accelerator program, the selected startups will receive up to $1 million in AWS credits. These credits will help the startups develop, train, test, and deploy their generative AI solutions using tools such as Amazon SageMaker and Amazon Bedrock. AWS will also provide access to other services like compute, storage, database technologies, and specialized AI chips like AWS Trainium and AWS Inferentia2. The program will help these startups scale their AI solutions globally by leveraging AWS’s infrastructure and expertise. In addition to AWS support, the startups will receive mentorship from business and technical experts tailored to their industry needs. According to Amitabh Nagpal, Head of Startup Business Development at AWS India, "Our $230 million commitment and global expansion of the generative AI accelerator reflects our continued focus on supporting startups to develop, build, and scale their unique ideas using generative AI." List of selected startups Convrse: Founded in 2021, Convrse is an AI tool that optimizes complex 3D objects or scenes for real-time applications. Serving industries like gaming, architecture, and healthcare, Convrse provides a solution to make 3D mesh models web-ready. House of Models: Based in Bengaluru, this startup utilizes large language models (LLMs) to generate digital content for brands, including images, videos, and product descriptions. It caters primarily to businesses looking to streamline their content creation. Neural Garage: Using AI to lip-sync actors with dubbed audio, Neural Garage offers seamless content creation for film, streaming, and advertising without compromising cinematic quality. Orbo.ai: Founded in 2019, this Mumbai-based startup provides hyper-personalized beauty and personal care recommendations by analyzing facial attributes and skin tones using generative AI. Phot.ai: Phot.ai simplifies photo editing and graphic design for e-commerce sellers through its AI-powered platform. Founded in 2022, it aims to help sellers optimize their workflows more efficiently. Unscript AI: Unscript AI is a SaaS marketing tool that creates studio-quality videos using real or virtual actors. It eliminates the need for costly physical production, allowing businesses to create personalized customer experiences. Zocket: Zocket focuses on simplifying digital advertising through generative AI, offering tools for ad creation, targeting, and analytics, making it accessible to businesses of all sizes. In addition to technical and financial support, the selected startups will have the opportunity to showcase their solutions on a global stage at AWS's annual re:Invent event in Las Vegas. This can accelerate their international growth and help them connect with potential investors and collaborators. Source: Indian Startup News #healthcarestartup #startup #AIhealthcare

"HearClear and 2050 Healthcare Join Forces to Expand Reach in Northern India" Working towards the goal, they recently came up with a new clinic in Lucknow for providing the latest hearing solutions to the people of the region. The entire initiative focuses on improving accessibility to hearing care solutions and encouraging hearing diagnostics and adoption of hearing aids by those facing hearing problems. Understanding that ear health is often neglected by people until it leads to serious problems, the collaboration will create the necessary awareness required to avoid any hearing impairment in a person. The strategic collaboration will enable HearClear to tab the offering of 2050 Healthcare, which resonates with the goal of the hearing care startup. It will allow the company to leverage the 24/7 home healthcare for elderly people offered by 2050 Healthcare. In the process, it will open the gateway to availing consultation from expert audiologists for a wide spectrum of hearing problems. Speaking on the occasion, Vineet Narang, the Founder & Managing Director of HearClear India, said, “The collaboration is a testament to our commitment to improving hearing care solutions across the country. It will come to aid in driving deeper penetration of advanced HearClear solutions among the target audience. In the pursuit of alleviating hearing problems, 2050 Healthcare will help us strategically tap their existing consumer base, which will play a crucial role in extending our services to a wide audience.” At the same time, Prasant Mohanty, Chief Business Officer of 2050 Healthcare, said, “The collaboration is a significant step towards expanding our healthcare services. Believing in convenient and hassle-free accessibility to quality healthcare solutions, the partnership with HearClear will help us add hearing care solutions as well to our offering. This move will play a crucial role in empowering the ear health of the masses, which is generally ignored when taking care of the entire well-being." SOURCE -APN News #HearClear #2050Healthcare #HealthcareExpansion #NorthernIndia #HealthcareCollaboration #HealthcareInnovation #HealthPartnership #HealthcareGrowth #MedicalInnovation

Venture fund Lightspeed, through its growth fund, is set to lead a $50-60 million deal with Qure.ai, which provides artificial intelligence-based decision support tools for diagnostic images, people aware of the matter said. This would be the third major deal from Lightspeed from its growth fund after having invested in quick-commerce firm Zepto and edtech company PhysicsWallah. The PhysicsWallah deal is yet to be formally announced. The funding in Qure.ai is likely to include a secondary share sale as well and is being finalised and will close within this month, people who know about the matter told ET. Qure.ai was a nominee in the Top Innovator category at The ET Startup Awards 2021. “Lightspeed is investing around $20-25 million and is looking to buy some in secondary share also. Overall, the round may end up being $50-60 million in size depending on the final secondary component,” a person aware of the matter said. “Existing investors will also put in primary capital.” In a secondary share sale, the capital doesn't go to company coffers as it changes hands between two investors. Started in 2016, Qure.ai has undertaken a significant shift in its client focus and most of its revenue now comes from overseas, a person in the know said. Chest X-ray reporting, TB care, lung nodule management and heart failure are some of the core areas where physicians use its AI services to understand and finalise diagnosis and treatment for patients. It works with companies and not consumers directly. Qure.ai chief executive Prashant Warier and Lightspeed declined to comment on the deal. Fractal Analytics-backed Qure.ai, since inception, has raised around $60 million and was last valued at around $233 million, per Tracxn that tracks startup funding data. It counts Peak XV Partners, Healthquad, Novo Holdings and MassMutual Ventures among its investors. “The deal also marks growing activity from Lightspeed, especially in growth stages. It has been competing aggressively for many deals this year,” another person aware of the matter said. Lightspeed has backed startups like Razorpay, Udaan, Acko and Darwinbox. The fund invested in Sarvam AI in one of the largest early-stage rounds in December last year. Based in Mumbai, Qure.ai reported revenue of Rs 91.3 crore in fiscal 2023 along with a loss of close to Rs 78 crore, as against Rs 39.3 crore and Rs 24 crore, respectively, the previous fiscal year. Last month, Qure.ai said it secured its 12th patent in India from the Indian Patent Office for “a system and method for detecting lung abnormalities in a medical image”. Globally, it has 29 patents, the company said at the time. Source: The Economic Times #Healthcarestartup #startup #innovation #funding

Commerce and Industry Minister Piyush Goyal will on Monday launch the Bharat Startup Knowledge Access Registry (BHASKAR) initiative which will serve as a central hub where startups, investors, service providers, and government bodies can come together to collaborate, exchange ideas, and accelerate growth. According to an official statement, it will also enhance collaboration among key stakeholders within the entrepreneurial ecosystem, including startups, investors, mentors, service providers, and government bodies. The primary goal of BHASKAR is to build the world's largest digital registry for stakeholders within the startup ecosystem. To achieve this, the platform will offer several key features such as networking and collaboration. providing centralized access to resources, creating personalized identification, enhancing discoverability, and supporting India's global brand. "BHASKAR will bridge the gap between startups, investors, mentors, and other stakeholders, allowing for seamless interaction across sectors," the statement said adding by consolidating resources, the platform will provide startups with immediate access to critical tools and knowledge, enabling faster decision-making and more efficient scaling. Through this initiative, every stakeholder will be assigned a unique BHASKAR ID, ensuring personalized interactions and tailored experiences acro .. Source: The Economic Times #healthcarestartup #startup #funding

"AI in Healthcare: A Hotspot for Startup Funding" Health systems are a large market for artificial intelligence startups, but companies selling to insurers or life sciences firms create value more quickly, according to an analysis by venture capital firm Flare Capital Partners. Most AI startups selling their products to health systems haven’t progressed past early-stage investment rounds. Just over 5% of those companies have reached a Series C raise or later, compared with nearly 10% of startups in life sciences and about 16% of companies selling to health plans. The gap suggests AI startups in the life sciences and health plan markets have been able to create more value for their customers, according to Flare. But those sectors also have higher operating margins, and can likely devote more resources — and time — to scale AI products. Still, health systems are a major target for AI startups, according to the report, which reviewed more than 4,000 venture capital deals. Companies selling to health systems have raised more than $23 billion from 2014 though the end of 2023. Nearly half of that investment has gone to clinical care startups, which offer AI tools for imaging, clinical decision support and diagnostics. Nearly $9.5 billion went to startups focused on care management and clinical operations, which includes tools for handling utilization and prior authorization, risk adjustment and other work key to value-based care, the analysis found. SOURCE - HEALTHCAREDIVE #HealthcareAI , #VentureCapital , #StartupFunding , #DigitalHealth , #HealthTech

" Look who just joined us – a fresh wave of innovation! " [Medidocs] ?

Online payment startups are now offering solutions for physical stores in the race to stand apart. August AI is helping users access personalised medical insights. Aurelle Health offers natural supplements to support women's hormonal health. A new trend is emerging among digital payment startups and payment companies—one that looks beyond the digital space into offline markets. As physical retailers increasingly demand integrated payment solutions, companies like Razorpay and Infibeam Avenues, are responding by introducing hardware such as POS devices and soundboxes. The goal is to capture a larger share of the offline market, competing not only with established players but also with newer entrants. Charting growth plans: Retailers typically use two types of payment processing hardware: card machines, primarily provided by banks, and soundboxes—devices that provide audible transaction confirmations. Soundboxes have become a popular payment solution, particularly for small merchants. This offline push by payment firms is largely driven by growing demand from retailers looking to digitise their payment systems and offer additional services like EMIs and buy now pay later (BNPL). Beyond the offline market, some companies, including Razorpay and Cashfree Payments, are also looking to access international markets for additional revenues. everal parts of India still lack quality healthcare and medical services. This disparity, according to entrepreneur Anuruddh Mishra, highlights the potential for technology to bridge the gap. Recognising the widespread gap in the healthcare system, Mishra started August AI in 2022. It is a health assistant chatbot that offers expert medical insights personalised to every user based on their health profile and history. Source : YourStory #healthcarestartup #startup #AI

VitalCaring's AI-driven Cognitive Care Pilot: Has shown impressive results, with patients experiencing significant cognitive improvements . The pilot program, which ran from October 2023 to May 2024, included 52 patients aged 54 to 92, with an average age of 77.45. Patients had various primary diagnoses, including cerebral infarction, brain tumors, dementia, Parkinson's disease, encephalitis, encephalopathy, and mild cognitive impairment (MCI). Key Highlights: 35% increase in Montreal Cognitive Assessment (MoCA) average score. 33% increase in Saint Louis University Mental Status (SLUMS) average score. 55% of patients improved by at least one cognitive level. 35% of patients achieved normal cognitive functional score by discharge. These results demonstrate the potential of AI-driven cognitive care to enhance personalized therapy for patients with cognitive disorders. By leveraging innovative tools like Constant Therapy's digital speech, language, and cognitive therapy platform, healthcare providers can extend exceptional care and support patient's journeys toward regaining independence safely in their homes . SOURCE- Globenewswire #AICognitiveCare #CognitiveHealth #PersonalizedTherapy #DigitalTherapy #ArtificialIntelligenceInHealthcare #InnovationInHealthcare #CognitiveRehabilitation #BrainHealth #Neuroplasticity #HealthTech #Caregiving #ElderlyCare

Naruvi Hospitals, Vellore, in collaboration with The Hindu, will organise a webinar on ‘Cancer: Prevention and Early Detection’ at 11:30 a.m. on Sunday (September 15) as part of their wellness series. Dr. T. Allwyn Yabesh, Senior Consultant in Medical Oncology, will discuss ‘Global Cancer Burden and Modifiable Risk Factors.’ Dr. Rahul Krishnan, Consultant in Surgical Oncology, will speak about ‘Hereditary Cancers and Prevention’, and Dr. G. Sindhu, Consultant in Medical Oncology, will discuss ‘Screening Methods for Average-Risk Individuals.’ https://www.thehindu.com/news/cities/chennai/webinar-on-cancer-prevention-and-early-detection-to-held-on-september-15/article68635084.ece Source: The Hindu #healthcarestartup #startup #oncology

Under this MoU, a federated learning platform across a variety of machine learning model pipelines, a quality-preserving database, an open benchmarking platform for comparing and validating AI models and a consent management system for research under the Ayushman Bharat Digital Mission (ABDM) would be developed by IIT Kanpur. The platform will subsequently be operated and governed by the NHA, thereby unlocking the immense potential of AI for improving health outcomes, the Union Health Ministry said in a statement. Speaking on the occasion, Union Health Secretary Apurva Chandra complimented the NHA and IIT Kanpur for signing "this very important MoU under the Ayushman Bharat Digital Mission that will provide an open public benchmarking platform for comparing and validating AI models". Highlighting the importance of this MoU, Chandra stated that "use of data for improving health outcomes is the envisaged goal of this partnership". "It will use the data available under the ABDM to create a public benchmark for AI models for quantifying and diagnosing diseases against which other AI models can be benchmarked," he added. Chandra said "one of the biggest issues related to AI models in the healthcare sector is the availability and efficacy of disease diagnosis data which will be tackled by this collaboration". Source : The Hindu #healthcarestartup #startupindia

India's Preparedness for Mpox Prevention: After battling Covid-19, India has valuable experience and infrastructure in place to tackle emerging health threats like Mpox. To enhance preparedness and prevention, 1.Surveillance and monitoring: Strengthen Mpox surveillance, monitoring, and contact tracing to quickly identify and contain outbreaks. 2..Vaccination: Leverage existing Covid-19 vaccination infrastructure to administer Mpox vaccines, focusing on high-risk groups like healthcare workers, LGBTQ+ individuals, and close contacts. 3.Public awareness: Launch targeted campaigns to educate the public about Mpox symptoms, transmission, and prevention measures. 4.Healthcare capacity: Ensure healthcare facilities are equipped to manage Mpox cases, with adequate testing, isolation, and treatment capabilities. 5.Research and collaboration: Encourage scientific research and international collaboration to improve understanding of Mpox and develop effective countermeasures. 6.Community engagement: Engage with vulnerable communities, addressing their concerns and promoting Mpox prevention and treatment. 7.Review and update guidelines: Regularly review and update Mpox guidelines, incorporating latest scientific evidence and global best practices. By building on Covid-19 experience and taking proactive steps, India can enhance its preparedness and effectively prevent and manage Mpox outbreaks. SOURCE-TIMES OF INDIA #covid19 #mpox #vaccination

Gurugram-based wealthtech start-up Centricity has raised $20 million in a seed funding round led by Lightspeed India Partners, with participation from returning investors Burman Family Office and Shantanu Agarwal, among others. The company is now valued at $125 million, according to cofounder and CEO Manu Awasthy. The round also attracted investment from Korean venture capital firm Paramark VC, as well as a group of prominent family offices and angel investors, including MS Dhoni Family Office, NB Ventures Family Office, Aakash Chaudhry (former CEO of Aakash Institute), Oyo’s Ritesh Agarwal, Nvidia’s Vishal Dhupar, MMG Group Family Office, and Action Tesa Family Office. Centricity plans to use the funds to scale its platforms, Invictus and One Digital, by investing in technology, talent, expanding private banking services, and pursuing strategic acquisitions. “We wanted to go deep into India that is why we are catering to the segment of ultra-high-net-worth individuals (UHNIs) that have around 70% of India’s wealth. We are also catering to the huge Indian market through a business-to-business-to-consumer (B2B2C) framework purely because no company in India has successfully built a distribution network. Our idea is to build India’s largest financial distribution company serving almost everyone possible,” Awasthy told ET. source: The Economic Times #healthcarestartup #startupnews

Taking your flu and pneumonia shots can significantly enhance your immunity, offering robust protection against seasonal flu, pneumococcal disease, and related complications. By getting vaccinated, you can reduce the risk of illness, hospitalization, and even death, while also enjoying long-term immunity and comprehensive protection. Moreover, vaccination can help prevent the spread of disease in your community, safeguarding vulnerable individuals like the elderly, pregnant women, and young children, thereby creating a healthier environment for everyone

NSRCEL IIM Bangalore, in collaboration with Daily Rounds, has launched a Healthcare Incubation Program aimed at fostering early-stage healthcare start-ups. This initiative is part of Daily Rounds' corporate social responsibility (CSR) efforts and is designed to drive innovation by addressing key challenges in the healthcare sector. The program is tailored to help entrepreneurs turn their healthcare innovations into market-ready products. Participants will receive comprehensive support, including mentorship from industry leaders, business development insights, guidance on crafting go-to-market strategies, and training on B2B and D2C sales. Additionally, start-ups will gain access to critical resources such as hospitals and labs for clinical trials and pilot testing, as well as potential funding sources and networking opportunities. Daily Rounds, a company founded in 2013 by Dr Deepu Sebin, started as a small email group for doctors and has since evolved into a leader in medical education technology. This partnership with NSRCEL aims to nurture the next generation of healthcare entrepreneurs who can solve niche but impactful challenges. "We are excited to launch our Healthcare Incubation Program in partnership with Daily Rounds. This collaboration underscores our commitment to supporting healthcare start-ups that have the potential to make a significant impact on the healthcare landscape in India," said Anand Sri Ganesh, CEO of NSRCEL.

T-Hub, India's leading startup incubator, has launched the AIC T-Hub Lab2Market program, an initiative aimed at transforming research into market-ready innovations. This program provides researchers and innovators with a pathway to turn their ideas into commercial successes. The primary goals of Lab2Market are to help startups develop Minimum Viable Products (MVPs) and scale them into successful businesses. Startups participating in the program will receive tailored support, including group learning sessions on product development, market strategies, and business model refinement. Each startup will benefit from personalised mentorship from industry experts, helping them overcome specific commercialization challenges. The program also offers market access events, where startups can showcase their innovations and connect with potential investors and partners. Out of 200 applicants, 23 startups have been selected for the first cohort based on their innovative solutions, commercialization potential, and expected market impact. These startups span a wide array of sectors, including sustainability, mobility, healthcare, fintech, agriculture, and more. Some notable startups include Declutter Solutions, ASMI Innovations, Bharat Plastipay, The Hydrogen Ecosystem, Abe Bikes, SmartKosh, Glassmart, Win Health, RhythmX, Cardiac Rehab, Transcript Life Sciences, NeoSurgix, Token-Disc, Blocks, Robic Rufarm, Bhaumya, Taejoon, Zentrix, and Achintya Products. Mahankali Srinivas Rao (MSR), CEO of T-Hub, said, "By supporting startups from diverse fields, we aim to drive significant growth for participants—helping them achieve commercialization, refine business models, and expand their market presence both domestically and internationally. This program will help startups catalyse transformation and evolve into established market players." The Lab2Market program is set to expand, potentially incorporating more cohorts and sectors and collaborating with other incubators across India to foster innovation at a national scale.

The World Health Organization (WHO) has launched a global plan to combat mpox, focusing on surveillance, prevention, readiness, and response strategies. Vaccines like Jynneos, ACAM2000, and LC16m8 are available for high-risk individuals, including close contacts and healthcare workers. The plan also emphasizes coordinated global efforts, equitable access to medical countermeasures, community engagement, research, and funding to support the response.

The AMTZ, which will be the country’s first full-fledged medical devices manufacturing zone, will take off in October, this year. Visakhapatnam: Vizag is set to become India’s medical technology capital, with the Andhra Med Tech Zone (AMTZ) and the Kalam Institute of Health Technology (KIHT) to come up in the city. The zone will be bringing down healthcare cost in India significantly, as it would produce a range of medical devices, including the high-end ones such as CT scan, X-ray tubes, IV diagnostic devices, ECG, ophthalmic equipment, heart and lung machines and ventilators. “Today, India imports more than 75 per cent of the medical devices required. In the high-end segment, the imports are to an extent of 95 per cent, touching Rs 24,000 crore annually. Once they are manufactured locally, the cost of these devices will be lower, which will get reflected in healthcare costs,” Jitendar Sharma. CEO of AMTZ and health advisor to the AP government, told this newspaper. The import dependency is about 85 per cent for products such as artificial dialysis apparatus & haemodialyser, defibrillator, lithotripsy equipment, ECHO, EEG, ECG, anaesthesia equipments, laparoscope and endoscope, 52 per cent for diagnostic imaging products like X-ray tubes, CT scan and MRI and 35 per cent for consumables like cardiac catheter, syringe, suture and dialysers. “We are even importing thermometers and X-ray films,” Mr Sharma pointed out. The AMTZ, which will produce most of these devices, will have 240 units, 52 of which have already been booked by both foreign and Indian companies. “Assuming that each of these units has a turnover of `50 crore, the total turnover would be Rs 12,000 crore, which is 50 per cent import substitution,” he explained. To support the zone’s efforts, the new KIHT is also ready for inauguration. It will have a unique role in bringing out hundreds of prototypes gathering dust in medical research labs and health universities. “We have identified at least 700 prototypes which can be made use of in the medical technology sector. We will be auctioning these prototypes and pay back the money to the respective institutions, while the industry gets to keep the product,” Mr Sharma, who is also the executive director of the institute, said. The first round of auction, involving 25 prototypes, will be held in three months through the Indian Medical Devices Manufacturers Association, the executive director added.

Researchers have found a connection between Alzheimer's disease and nighttime light pollution, suggesting that exposure to artificial light at night may increase the risk of developing Alzheimer's, particularly for people under 65 . The study, published in Frontiers in Neuroscience, used satellite data to determine the average nighttime light intensity in the US between 2012 and 2018 and found a positive association between Alzheimer's prevalence and exposure to light at night . While the exact cause of Alzheimer's is still unknown, scientists believe it's a complex combination of genetic, health, and lifestyle factors, together with age-related changes in the brain . Some risk factors, like age and family history, can't be changed, but others, like smoking, physical inactivity, and poor sleep, may be modifiable . The researchers hope that their findings can help educate people about the potential risks of light at night and encourage them to make easy lifestyle changes, such as using blackout curtains or sleeping with eye masks

Apollo Hospitals, India's largest vertically integrated healthcare provider, announces the launch of the Apollo Research Academy, an initiative aimed at positioning Apollo as a global leader in healthcare research and innovation. The Academy, led by Professor Ravi P Mahajan CBE, is set to harmonize the efforts of various Apollo entities, including Apollo Health Education and Research Foundation (AHERF), Apollo University, ARI, Apollo Research Centre, Apollo Clinical Innovation Group, and others, to create a cohesive and internationally recognized hub of research excellence. Dr. Prathap C. Reddy, Founder & Chairman, Apollo Hospitals said: "The Apollo Research Academy embodies the spirit of "One Apollo," leveraging the collective strengths of the group's diverse research and educational organizations. This strategic alignment is designed to enhance Apollo's research potential, foster collaboration, and build partnerships with eminent national and international funding and research organizations. By integrating the expertise of these entities, the Academy aims to transition from being "research active" to becoming a global leader in healthcare research and innovation, with a significant impact on health care and policy."

Healthtech start-ups are reshaping healthcare in India. These start-ups are leveraging technologies like Artificial Intelligence to transform patient-centric care. City-based BeAble Health, launched in 2017, is one such start-ups operating in this sector with its focus on game-based rehabilitation for patients suffering from hemiplegia/hemiparesis due to conditions such as stroke or traumatic brain injury. Patients suffering from conditions such as spinal cord injury, multiple sclerosis, cerebral palsy, frozen shoulder and others can also benefit from their AI-backed rehabilitation product. The start-ups is a spinoff from the first batch of Fellowship in Healthcare Entrepreneurship at the Centre for Healthcare Entrepreneurship – IIT Hyderabad. Founder and CEO, Habib Ali, and Co-Founder and CMO at BeAble Health, K G Sreehari, speak to Bizz Buzz about the solution that has supported patients in faster recovery, and improved motor function.

The pharmaceutical industry plays a crucial role in healthcare, but it also has a significant environmental impact. Clinical trials are a critical component of drug development, but they can be resource-intensive and contribute to carbon emissions. Embracing sustainable clinical trials can help reduce this impact and achieve net zero.

The Institution of Engineering and Technology (IET) hosted the 6th edition of Future Tech Congress, focusing on the theme “India’s Component Conundrum,” at Sheraton, Whitefield, Bengaluru. The one-day event brought together industry experts to discuss the challenges and opportunities in building a robust Electronic System Design and Manufacturing (ESDM) ecosystem in India. The conference concluded with actionable recommendations for stakeholders aimed at driving growth and innovation in India’s ESDM sector. Padma Bhushan recipient Dr Arogya Swamy Paul raj, an Indian-American electrical engineer and academic, delivered the Super Keynote, emphasising the need for India to ascend the value chain in high-tech sectors. “India stands at a critical juncture where fostering innovation, persistence, and entrepreneurship is essential to building a robust domestic capability in electronic components, particularly semiconductors,” said Dr Paul raj. He further highlighted that India must address challenges such as intellectual property, high skill requirements, and intense R&D demands to excel in advanced technology segments. The event addressed the urgent need for India to reduce its dependency on imported components, a key factor in realising the nation’s $30 trillion economy goal by 2047. Discussions centred on three key technologies—Generative AI, Industrial Metaverse, and Quantum Technologies—and their impact on the Healthcare, Manufacturing, and Mobility sectors.

Hypertension, or high blood pressure, is a serious health concern, but a recent study on a new hypertension polypill has shown promising results . The polypill, called GMRx2, combines three anti-hypertensive drugs in low doses into a single pill. In the study, 81% of participants who took GMRx2 achieved blood pressure control after just one month, compared to 55% of those who received standard care. This improvement was sustained at six months, with 82% of participants achieving blood pressure control. The study's results are significant, as they suggest that this new polypill could be a game-changer in reducing rates of cardiovascular disease, particularly in countries with the highest burden .

Medical tourism start-up, Global Care-Lavanya Medicare Solutions Pvt Ltd, has raised $3 million as a strategic investment. The investment has been received by 35North India Discovery Fund II (IDF II) and its affiliates. As per the company statement, through this investment, 35North IDF-II will support Global Care’s aim to bridge healthcare divides worldwide. Additionally, it will help to build clinical excellence through strategic consulting and also facilitate convenient access to world-class patient care. “We strongly believe in both the company and the sector. The sector is benefiting from cutting-edge medical care across specialties in India, Turkey, Dubai, Egypt, Germany, and Thailand. This is coupled with the availability of high-end medical equipment and the time and price competitiveness of these destinations,” said Ashwani Singh, Managing Director at 35North.

Business-to-business (B2B) healthcare financing firm HealthCRED announced that it raised $1.2 million in a seed funding round led by Antler India, TRTL VC, DeVC, iSeedVC, and Angel List India. The round saw the participation of angel investors such as Internet and Mobile Association of India (IAMAI) President Subho Ray, Uni Cards chief executive officer (CEO) Nitin Gupta, among others. The firm will utilise the raised capital to expand operations in the southern and western parts of the country. Furthermore, the seed capital will be used to hire fresh talent and develop B2B loan onboarding and loan management systems (LMS). The Delhi-based company has a post-money valuation of $13 million, according to data from market intelligence platform Tracxn. “With the rapid penetration of health insurance in the post-COVID scenario, there has been increased working capital management stress for hospitals and health service providers (HSPs). The key factor is the delay associated with the realisation of insurance receivables,” said Shrey Jain, co-founder and CEO, HealthCRED